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ABSTRACT
In 2017, the United States Department of Health and Human Services (HHS)
declared the opioid epidemic a public health emergency. The opioid epidemic has
become widespread because of over prescription and extreme addiction. In recent years,
the crisis has become dire because of the staggering annual death toll from overdoses.
Although the number of opioid-related deaths has risen, so too have the innovations
designed to combat opioid abuse and overdoses. The use of naloxone is a safe and
reliable option for treating overdose victims. In fact, many first responders are primarily
relying on the medication in such emergencies. This study explored message-design
components for persuading individuals to purchase Narcan nasal spray (a Nalaxone
product). Guided by the Extended Parallel Process Model, the project employed three
message framing techniques, including gain-frame/loss-frame, labeling and medical
stigmatization through language, and linguistic agency assignment. 304 participants read
one of eight messages and completed a corresponding survey. The first measure of
behavioral intent, which was acceptance or refusal of the coupon code for the Narcan
nasal spray, was predicted only by susceptibility and system-efficacy. The second
measure, intent to seek additional information regarding Narcan, was predicted by
severity, susceptibility, and system-efficacy. The third measure, intent to own Narcan in
the future, was predicted by susceptibility and response-efficacy. Optimistic bias and
self-efficacy did not predict any of the three behavioral intent variables. However, when
separate from the other independent variables, optimistic bias predicted all three
behavioral intent variables.
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CHAPTER I - INTRODUCTION
The Opioid Crisis
In 2017, the United States Department of Health and Human Services (HHS)
declared the opioid epidemic a public health emergency (HHS, 2018a). Alex Azar,
Secretary of HHS, described the opioid crisis in this way:
The opioid misuse and overdose crisis touches everyone in the United States.
In 2016, we lost more than 115 Americans to opioid overdose deaths each
day, devastating families and communities across the country. Preliminary
numbers in 2017 show that this number continues to increase with more than 131
opioid overdose deaths each day. The effects of the opioid crisis are cumulative
and costly for our society—an estimated $504 billion a year in 2015—placing
burdens on families, workplaces, the health care system, states, and communities.
(HHS, 2018b, p. 1).
The general knowledge of opioids is growing as the number of people dependent
on the medications increases. According to the American Psychiatric Association (2018),
nearly one in three Americans knows at least one person addicted to opioids. Opioids are
a class of pain-relieving drugs that interact with opioid receptors in the body to calm
nerves, sometimes creating a feeling of euphoria for the recipient that can become very
addictive, according to the National Institute on Drug Abuse (2018a). Again, this sharp
rise in the abuse of opioids and overdose deaths is what led the HHS and other
government agencies to declare the trend an epidemic.
The Centers for Disease Control and Prevention (CDC) attribute the rise of the
epidemic to three distinct waves of opioid use and abuse. First, there was an initial rise in
1

medical providers prescribing opioids in the 1990’s (CDC, 2017a). According to Liu, Pei,
and Soto (2018) “the increase in opioid prescriptions was influenced by reassurances
given to prescribers by pharmaceutical companies and medical societies claiming that the
risk of addiction to prescription opioids was very low” (para. 1). The second uptick in the
use of opioids resulted from a rapid increase in deaths from heroin around 2010. The
increase in heroine-related deaths partially originated from regulatory efforts making
prescription opioids harder to obtain; instead, individuals struggling with addiction
sought means other than prescriptions to obtain opioids (CDC, 2017 a).
Finally, the most recent wave of the epidemic is due to an increase in deaths due
to illicitly-manufactured opioids, such as fentanyl, in 2013 (CDC, 2017a). Fentanyl is
typically used for treating advanced cancer pain and is 50 to 100 times more potent than
morphine (CDC, 2017b). This third wave is particularly dangerous as “the illicitlymanufactured fentanyl (IMF) market continues to change, and IMF can be found in
combination with heroin, counterfeit pills, and cocaine” (CDC, 2017a, para. 6).
According to the U.S. Drug Enforcement Agency (n.d.), “many users believe that they
are purchasing heroin and actually don’t know that they are purchasing fentanyl – which
often results in overdose deaths” (para. 1). As the market for opioids continues to grow
and evolve, it is critical to address the crisis to prevent a fourth, deadlier wave in the
future.
Opioid addiction
The opioid epidemic has become widespread because the drugs are
overprescribed and are also extremely addictive (CDC, 2017c). The American Addiction
Centers (2019) report that 9.7% of women and 12% of men admit to using Oxycontin or
2

Vicodin while at work. An additional 1% of women and 1.5% of men admit to using
heroin while at work (AAC, 2019). Although heroine is an illicit drug, other forms of
opioids like Oxycontin or Vicodin are regulated prescriptions that can be obtained from
physicians. Not surprising then that the CDC reports that one in four patients receiving
long-term opioid therapy will struggle with an addiction to the drug (CDC, 2017c).
Pharmaceutical companies have benefited greatly from the widespread
prescribing of opioids, and in some cases, they engaged in legally questionable actions to
keep them on the shelves. In fact, Purdue Pharma, the company that manufactures the
opioid product OxyContin, lied to the public and other stakeholders about the true
addictive nature of the drug (Mole, 2018). After pleading guilty in a lawsuit, the family
that owned Purdue Pharma then quietly started a second company called Rhodes Pharma,
manufacturing generic brands of the same product. In 2019, both companies are being
sued by New York and other states for “putting hunger for profits over patient safety”
(Associated Press, 2019, par 1). The state of New York alone is asking for tens of
millions of dollars, as well as requiring the companies to establish a fund to curb the
crisis in the state. Oklahoma settled its lawsuit with Purdue Pharma for $270 million
(Wildeman, 2019).
The opioid crisis has become so dire that the Food and Drug Administration
(FDA) has warned veterinarians to be aware of people trying to get opioid prescriptions
for their pets with the intention of using the pills or distributing them to others (FDA,
2018). As the number of those addicted grows, users will go to great lengths to obtain
more opioids. In some cases, theft behavior evolves in parallel with the development of
compulsive drug use behavior. As casual experimentation gives way to full-blown
3

addiction, the need to obtain and use that substance takes priority over everything else in
life. People don’t behave like themselves and will go to great lengths to get more of the
drug – even if that means stealing from friends and family (AAC, n.d., para 12).
The overprescribing of opioids cannot be understated in its contribution to the
crisis. In 2017, more than 191 million prescriptions were dispensed in the United States
alone, or nearly 1.5 prescriptions per household annually (CDC, 2017d). In 2011, the
opioid medication hydrocodone was the most prescribed pharmaceutical with 131.2
million prescriptions. The second most prescribed drug in 2011, a cholesterol-lowering
medication, was prescribed nearly 40 million times less than hydrocodone (DeNoon,
2011). Seven years later, even after a nationwide-push for physicians to treat pain in ways
other than prescribing opioids, hydrocodone remained the highest prescribed medication
in several states, including Alabama, Alaska, Georgia, Idaho, Indiana, Illinois,
Mississippi, Nebraska, Oklahoma, and South Carolina (Goetz, 2018). Additionally, in
Tennessee, the top prescribed drugs are buprenorphine and naloxone, medications used to
help those with opioid addiction (Goetz, 2018).
Complicating the overprescribing of opioids is the finding that approximately
28.5% of prescriptions are distributed without any pain-related justification from the
prescribing providers (Sherry, Sabety, & Maestas, 2018). Based on the number of
prescriptions cited above, in 2017 alone, approximately 955,000 opioid prescriptions
were given without any clinical justification. Further, pharmaceutical industry marketing
has spent large sums of money specifically targeting physicians, a practice that has
directly resulted in higher overdose rates (Hadland, Rivera-Aguirre, Marshall, & Cerdá,
2019). The marketing tactics include providing meals for physicians, a practice that has
4

led to increased prescribing (Gershman, 2019). Although marketing drugs to physicians
is very common, Purdue Pharma understood the extremely addictive nature of opioids as
early as 1999 (Keshner, 2018). The company failed to disclose the information to
physicians and regulators while continuing to market the drugs (Meier, 2007).
While prescription opioids have garnered much attention, heroin is also extremely
potent and addictive. It is also more likely that people will misjudge the amount of heroin
being consumed because of its unregulated production and distribution (AAC, 2018a).
While some pervasive cultural assumptions point to minorities and lower socio-economic
persons as primary users, recent surges in heroin use has been attributed more to women,
non-Hispanic whites, and people with private health insurance (Jones, Logan, Gladen, &
Bohm, 2015). Both legal and illegal opioid addiction can destroy lives of people from all
races, genders, and classes.
To curb the opioid crisis, the US House of Representatives passed a bill directing
the National Institutes of Health to develop non-addictive painkillers, change the way
prescription pills are distributed, and require the inclusion of addiction history in patient
medical records as of June of 2018. The bill also provides agencies with additional tactics
for preventing the transport of opioids into the United States (Sotomayor, 2018).
The CDC also released a new set of opioid prescription guidelines for chronic
pain (CDC, 2018). Although some lawmakers advocated for a hard cap to the amount of
prescriptions physicians can prescribe, there are drawbacks to this type of regulation. For
example, chronic pain sufferers fear that strict regulations for opioid prescribing practices
may worsen their quality of life (Joyce, 2018). There are two competing needs at play:
The need to address the growing opioid epidemic and the need to provide care for people
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with chronic pain. As one chronic pain patient stated, “It's the difference between laying
[SIC] in bed crying and getting up and going kayaking” (Joyce, 2018, para. 1). “We are
not criminals, we are just in pain” (para. 5).
Opioid related deaths
In recent years, the crisis has become dire because of the staggering annual death
toll from opioid overdose (NIDA, 2018b). Over two million people in the United States
currently suffer from an opioid dependency (Wolf, 2019), and this opioid dependency
increases their risk of experiencing an early death by 19.8% (Hser et al., 2017). An
overdose occurs when too many opiates attach to the opioid receptors in the brain, and
breathing is suppressed to a dangerously low rate, or even stopped completely (White &
Irvine, 1999). According to the CDC (2017a), the number of opioid-related deaths in
2016 soared above 63,600. Opioids are now cited as one of the top contributing factors
for the unprecedented life expectancy decline in the United States (Thompson, 2018).
While the unregulated nature of heroin has contributed to deaths, an estimated 40% of
overdose cases result from prescription opioids (CDC, 2017c).
Interestingly, the elderly population experiences a high risk of opioid overdose.
“As the baby boomer generation ages and the population of older adults in the United
States grows, opioid misuse among older Americans is becoming an increasingly urgent
public health concern” (SAMHSA, 2017a, p. 1). While Malec and Shega (2015) reveal
that the addiction risk is lower in the elderly population, older patients are often
overprescribed pain-relieving medication in quantities far surpassing manufacturer
recommendations (AAC, 2018b). Finally, as people age, their memory can deteriorate,
potentially increasing the risk of overdose. “[The elderly] might not fully hear their
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doctor’s instructions, they might take the wrong dose, or forget if they took it already—
all of which can lead to misuse, significant negative side effects, or even overdose”
(AAC, 2018b, para 3).
The CDC has focused on four tactics to prevent opioid overdose. The first tactic is
to improve prescription practices through clearer clinical guidelines. “Recommendations
focus on the use of opioids in treating chronic pain outside of active cancer treatment,
palliative care, and end-of-life care” (CDC, 2017f, para 2). The second tactic is
preventing opioid use disorder by preventing exposure to the drug through prescription
monitoring programs, state prescription laws, formulary management strategies in
insurance programs, provider education, patient education, quality improvement
programs in health care systems, and generally raising awareness (CDC, 2017g). The
third approach is treating those with opioid use disorder with evidence-based treatments
such as medication-assisted therapy. Medication-assisted therapy is a comprehensive
treatment that combines the use of medications such as methadone, buprenorphine, or
naltrexone to assist individuals to stop using opioids. This approach is often coupled with
counseling and behavioral therapy (CDC, 2017h). The final approach is to actively
reverse overdose occurrences using Naloxone, the medication employed to immediately
reverse the fatal results of opioid overdoses (CDC, 2017i).
Naloxone
Although the number of opioid-related deaths has risen, so too have the
innovations designed to combat opioid abuse and overdoses. For instance, suboxone was
designed to curb opioid addiction withdrawal as people attempt to stop using the drugs.
However, likely the greatest weapon against opioid-related deaths is the drug Nalaxone,
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which has been used by first responders and medical centers (Sauers, 2019) to rapidly
reverse and block the adverse effects of an opioid overdose, thereby quickly returning the
respiration rates of the victim to normal measures (NIDA, 2018c).
Nalaxone was originally discovered and patented in 1961 to treat constipation
caused by chronic opioid use (Cordant Health Solutions, 2017). Second, the FDA
approved the drug as an overdose treatment in 1971. Finally, the first take-home kits for
laypersons were distributed as a pilot program in 1996. As of 2015, over 26,000 lives had
been saved thanks to naloxone (Wheeler, Jones, Gilbert, & Davidson, 2015). Weiner,
Baker, Bernson, and Schuur (2017) measured the overall success of the drug and revealed
that naloxone saved the victim 93.5% of the time, and 84.3% of survivors were still alive
one year later.
The use of naloxone is a safe and reliable option for treating victims of opioid
overdose. In fact, many first responders are primarily relying on the medication in
overdose emergencies (NPR, 2018). There are no life-threatening side effects to
naloxone, only minor discomfort after being revived (NIDA, 2018c). However, certain
stakeholders including various first responders and media outlets remain uneducated
about the properties of Naloxone and its ease of use. This has unfortunately slowed the
diffusion of this particular innovation (Bagley & Bright, 2018).
Because of the lack of available information regarding the life-saving drug, as
well as the fear of potential consequences for requesting or possessing Naloxone (Green
et al., 2017), some have expressed some uneasiness surrounding the medication.
However, given the staggering number of opioid overdose-related deaths occurring every
day in the United States, it is imperative that health communicators develop messages
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that educate the public and first-responders as well as managing misinformation
surrounding Naloxone. In other words, communicators must craft messages that inform
the public about the drug while persuading them—especially those with friends or family
members who have struggled with an opioid addiction—to carry it regularly.
The current study explores message-design components for persuading
individuals to purchase the Narcan nasal spray (a Nalaxone product). Guided by the
Extended Parallel Process Model (EPPM), the project employs three message framing
techniques, including gain-frame/loss-frame, labeling and medical stigmatization through
language, and the linguistic agency assignment. The following chapter provides an indepth review of literature concerning the theoretical framework, message design
components, and health communication campaign techniques.

9

CHAPTER II – LITERATURE REVIEW
Health Communication Campaigns
The National Cancer Institute (2002) developed a four-stage process for
developing health communication campaigns. These stages include campaign planning,
message design and testing, campaign implementation, and evaluation. The first two
stages, campaign planning and message design and testing, are most pertinent to the
current study. In terms of planning and strategy development, communication campaign
designers should first conduct a conceptual analysis (Silk, Atkin, & Salmon, 2011) to
better understand the public health concern. In this phase of planning, the target audience
should be identified (Randolph & Viswanath, 2004) along with the focal segment(s) and
focal behavior(s) (Silk, Atkin, & Salmon, 2011). Focal segmentation refers to distinct
groups in the population that need to change a specific health behavior. For campaign
purposes, focal segmentation parameters must be established. For example, a recent ecigarette campaign experiment targeting three different groups (old smokers, reluctant
smokers, and young smokers), established demographic, cognitive, and behavioral
parameters before sampling (Yang, Liu, & Popova, 2018).
Focal behaviors are the health-related behaviors that need to be adopted or
discontinued by the focal segment. The behavior focus should always be a specific,
discrete action (Atkin, 2001). Campaign designers must decide whether to focus on
encouraging target audiences to add or eliminate related behaviors (Perloff, 2010). For
example, a campaign in Denver promoted the prevention of sexually transmitted diseases
and identified male and female condom use as the main focal behavior for the campaign
(Salyers Bull, Cohen, Ortiz, & Evans, 2002). The campaign focused specifically on
10

encouraging condom use for those not already engaging in the behavior. Once the focal
segments and focal behaviors are established, campaign designers should identify the
determinants, including attitudes, beliefs, knowledge, social influences, and
environmental forces that contribute to health behaviors (Silk, Atkin, & Salmon, 2011).
Identifying these social determinants can assist campaign designers in identifying the
most promising pathways and developing campaign objectives (NCI, 2002; Silk, Atkin,
& Salmon, 2011).
The second stage of the campaign process is pretesting concepts, messages, and
materials. Developing the right message can make or break a campaign. When
implemented poorly, health campaigns may fail to meet goals and can even lead to
boomerang results, or outcomes directly opposed to intended goals (Dillard & Shen,
2005). Several variations of the campaign message(s) should be created and tested on a
small sample of the focal segment. Knowing which messages will be most effective will
save program campaign resources by ensuring that the process is not implemented with
an ineffective message (NCI, 2002).
In health and risk message design, rigorous approaches “determine which
variations matter for whom and in what contexts, with the ultimate goal of designing
more effective persuasive messages to have a positive impact on health behavior”
(Harrington, 2015, p. 103). O’Keefe (2015) argues that all message design choices should
be evidence-based, specifying that evidence should come from replicated trials, effect
sizes, and random-effects meta-analysis.
Another integral characteristic to any campaign is its credibility (Iyengar &
Valentino, 2000). Message designers should ensure that the source of the message is
11

perceived as credible by the focal segment. Source credibility can be defined as “the
extent to which the information and advice came from a knowledgeable source, was
prepared by an expert, seemed impartial, and was readily available” (Briggs, Burford, De
Angeli, & Lynch, 2002, p. 328). High perceptions of source credibility often lead to
higher perceptions of self-efficacy, perceptions of threat severity, and behavioral
intention rates (Phua, 2016; Haase, Betsche, & Renkewitz, 2015; Kareklas, Muehling, &
Weber, 2015). Health-related messages must also include sufficient evidence to establish
the seriousness of the threat. Additionally, special attention should be paid to the
evidence employed in messages to ensure that the campaign messages do not backfire,
resulting in unintended consequences for the campaign (Silk, Atkin, & Salmon, 2011).
The current project focuses on the message design components that may influence
individuals’ likelihood to alter their behavior for the safety of others, including their
friends and family members. In most cases, someone experiencing an opioid overdose is
unlikely to have the presence of mind or the physical ability to administer Narcan to
themselves. Therefore, developing compelling messages that encourage others to carry
Narcan, not simply individuals dependent on opioids, is the intent of the current study.
While there are few examples of Narcan-centered health communication campaigns,
there has been a recent surge of opioid-centered campaigns in the United States sparked
by the widespread opioid crisis.
Opioid health communication campaigns
Attempts to address the opioid crisis using health communication campaigns have
emerged at the national, state, and even local levels. At the national level, the CDC
(2019) created its national campaign entitled “Rx Awareness,” with a goal to “increase
12

awareness that prescription opioids can be addictive and dangerous and to decrease the
number of individuals who use opioids recreationally or overuse them” (CDC, 2019,
para. 1). The campaign employs stories from real people affected by opioids either
directly or indirectly. The White House also released its own campaign called “The Crisis
Next Door” that allows victims to upload their own videos to share their experiences with
others in hopes of preventing addiction and providing help (Office of National Drug
Control Policy, 2019).
As of June 2017, the Substance Abuse and Mental Health Services Administration
(SAMHSA) had identified 15 state-wide communication campaigns addressing the
opioid crisis in 12 different states (SAMHSAb, 2017). These state-wide opioid
campaigns include the “Dose of Reality” campaign in Minnesota, the “Anyone,
Anytime” campaign in New Hampshire, the “North Dakota Prescription Drug Abuse
Campaign” in North Dakota, the “Prescription for Prevention” campaign in Ohio, the
“OvedoseFreePA.org” campaign in Pennsylvania, the “Use Only as Directed” campaign
in Utah, the “Vermont’s Most Dangerous Leftover” campaign in Vermont, the “Sink or
Swim” campaign in Virginia, and the “Dose of Reality” and “Good Drugs Gone Bad”
campaigns in Wisconsin. Some of the campaigns established specific target audiences.
Three campaigns specifically targeted young people, including public service
announcements in Delaware targeting persons 12-25, the Generation RX Project in
Georgia targeting persons 12-25, and public service announcements in Maryland aimed at
persuading college students. Finally, the “Parent Up” campaign in Vermont targeted
parents, and the “Don’t Run, Call 911” campaign in Delaware targeted overdose victims.
Finally, cities and municipalities have also increased communication campaign efforts to
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curb the crisis, such as the Opioids Solutions RVA campaign in the Richmond Virginia
area (Rojas, 2019).
Message design is critical for campaign success, and messages should increase
people’s knowledge surrounding a health threat while also encouraging them to modify
their behavior through persuasive tactics (NCI, 2002). For example, in the CDC’s
Awareness RX campaign, one of the campaign messages features a picture of a pill bottle
accompanied by the quote “Prescription opioids can be addictive and dangerous. It only
takes a little to lose a lot” (CDC 2017e, para. 2). This message is intended to increase
readers’ knowledge more than modify their behavior by raising awareness to the inherent
dangers of opioid use. In another campaign message, a picture of a woman is captioned
with the quote “I’m not supposed to be the one to pick which sneakers I’m going to bury
him in” (CDC, 2017d, para. 3). This message is intended to conjure mental images of the
woman burying her son, and the message designers are trying to invoke the readers’
emotions while persuading them of the danger posed by opioids.
Health campaign messages should increase the knowledge of the audience while
persuading individuals that they are at risk for the given threat. The theoretical
framework of the EPPM explains how constructing messages that cause people to feel
susceptible to certain risks may serve as a catalyst for behavior change. The following
section provides an overview of the theoretical tenets of the EPPM.
Extended Parallel Process Model
Developed by Kim Witte (1992), the EPPM was modeled to explain how people
process fear appeal messages (Lewis, Watson, & White, 2013). The basic premise of the
EPPM is that a message recipient is more likely to adopt a recommend behavior
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change when both the perception of threat and the perception of efficacy are high. The
EPPM has been used in many contexts, including the H1N1 virus and its corresponding
vaccine (McGlone, Bell, Zaitchik, & McGlynn III, 2013), germs from urine and feces and
hand-washing (Botta, Dunker, Fenson-Hood, Maltarich, & McDonald, 2008),
cardiovascular disease and proper vitamin intake (McKay, Berkowitz, Blumberg, &
Goldberg, 2004), radon and radon abatement systems (Dragojevic, Bell, & McGlone,
2014), and others (Witte & Allen, 2000).
Previous fear appeal models
For decades, scholars have investigated the role of fear on human behavior
(Dillard, 1994; Witte, 1992). The first phase of fear appeal theories and research was
focused on the drive models. The drive models situate fear as a “stimulus-producing
response that has the functional properties of a drive” (Janis & Feshbach, 1953, p. 90).
The drive models are a four-step process that begin with 1) the individual receiving a fear
appeal message, 2) the individual experiencing an arousal of fear, 3) the individual
wanting to reduce the level of fear, and 4) the individual changing his or her attitude or
behavior (see figure 1; Dillard, 1994).
In early fear appeal literature, scholars assumed greater levels of fear resulted in a
greater intent to control the danger. In other words, “One would predict that the group
displaying the greatest degree of residual fear would be most strongly motivated to ward
off those internal symbolic cues which [are] salient during and immediately after the
communication” (Janis & Feshback, 1953, p. 90). However, there were problems with
drive models that pushed scholars to develop a more comprehensive approach better in
explaining the cognitive and emotional aspects of fear appeals (Dillard, 1994). Leventhal
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Figure 1. Original Drive Model
(Dillard, 1994)

(1970) offered several critiques of drive models, including the lack of scholarly evidence
that fear is the mediator of attitude or behavior change, the lack of specific variables
capable of changing the optimal level of fear, and the lack of research supporting the
capability of drive models to function as anything beyond a low-order descriptive
hypothesis.
To address his own objections to the drive models, Leventhal (1970) proposed the
parallel response model (PRM) (see figure 2). The PRM posits that once a fear appeal is
encountered, audiences will engage in two succinct reactions. First, an individual will
simultaneously experience an awareness of danger and the creation of fear. Next, the
individual will attempt to control both the danger and the fear. While distinct processes,
the fear response and danger response may impact one another in either a facilitative (i.e.
when danger-control efforts reduce fear) or disruptive (i.e. when fear-control efforts
prevent danger-control efforts) manner.
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Figure 2. Parallel Response Model
(Dillard, 1994).

However, because of several shortcomings to the PRM, including its lack of
precision “in specifying what conditions lead to danger or fear control processes” (Witte,
1992, p. 333), a new wave of fear appeal theories, known as the expectancy value
theories, emerged. The most notable include the Protection Motivation Theory (PMT)
(Rogers, 1975) and the Subjective Expected Utility Theory (SEU) (Sutton, 1982). These
models “deemphasized the role of fear arousal in favor of cognition” (Witte, 1992, p.
334). Ultimately, decades of research on fear appeals would inform the creation of the
Extended Parallel Process Model, a more comprehensive explanation of fear and danger
control responses.
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Fear appeals are often used in health communication campaigns, and they can be
defined as, “persuasive communication that attempts to arouse fear in order to promote
precautionary motivation and self-protective action” (Ruiter, Kessels, Peters, & Kok,
2014, p. 65). Health campaigns that employ fear appeals “are based on the assumption
that by vividly demonstrating negative and life-endangering consequences of risk
behaviors, people will be motivated to reduce their current risk behavior and adopt safer
alternative behaviors” (Ruiter, Kessels, Peters, & Kok, 2014, p. 63).
Most fear appeals are employed to accomplish two purposes. First, an effective
fear appeal should present a threat perceived to be dangerous by the message recipient.
Second, the message should present a viable option for averting the threat (Witte, 1992;
Witte & Allen, 2000; Ruiter, Kessels, Peters, & Kok, 2014). For example, a fear appeal
message used in a texting and driving campaign would present the threat of people killing
either themselves or someone else in a distracted driving incident. Next, an appropriate
behavior for averting the threat, which could include mobile driving applications or
simply a commitment to quit texting, would be presented. The success of this fear appeal
would depend heavily on the audience’s perception of the threat presented in the
message. Threat perception can be measured through perceived severity and
susceptibility. When trying to persuade individuals to engage in the prescribed behaviors,
messages should include strong efficacy components. Specifically, messages should
convey strong perceptions of self-efficacy and response-efficacy for message recipients.
In the presence of fear appeals, audience members need reinforced messages of efficacy
to engage in the prescribed behaviors.
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Perception of threat severity and threat susceptibility
Strong threat components in fear appeals produce high levels of both severity and
susceptibility for message recipients (Witte & Allen, 2000). Witte and Allen (2000)
define severity as “the magnitude of harm expected from the threat” (p. 592) and
susceptibility as “the degree to which one feels at risk for experiencing the threat” (p.
592). The first proposition of the EPPM is that if the combination of these two
components results in a low overall perception of threat then there will be no further
processing of the message, ultimately resulting in a failed attempt to change behavior
(Witte, 1992). While these components primarily focus on the perception of threat to
one’s self, research shows that threats to others can also motivate people to act (Sampson
et al., 2001). This can be referred to as perceived threat to others (Roberto, MurrayJohnson, & Witte, 2011). For example, persuading a new mother not to put blankets or
pillows in a crib with a newborn in order to avoid suffocating the child could be
successful, not because the mother is afraid of suffocating, but because she is afraid of
her newborn suffocating.
Ruiter, Kessels, Peters, and Kok (2014) argue that while severity is often the most
visible component in fear appeals, it is also the least persuasive. A threat may appear to
have very intimidating consequences, but if the message recipient does not feel
susceptible, they are unlikely to experience a high level of fear (Witte, 1992). Thus,
people are unlikely to change their behavior unless they feel susceptible to a particular
risk. For the current study, threat severity measured participants’ perception of the opioid
crisis, and how harmful it could be to their loved ones. Threat susceptibility measured
participants’ perception of the likelihood that their loved ones could be a victim of the
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opioid crisis. Both are measurements of perceived threat to others and not perceived
threat to self.
Perception of self-efficacy and response-efficacy
Self-efficacy is defined as “people’s beliefs about their capabilities for exercising
control over their own level of functioning and over events that affect their lives”
(Schreurs, Van Emmerik, Notelaers, & De Witte, 2010, p. 60). Response-efficacy is
defined as “belief as to whether a response effectively prevents the threat” (Witte, 1992,
p. 332). Together, these two components create an overall perception of efficacy. One of
the main propositions of the EPPM is that a low perception of efficacy (when perception
of threat is high) will result in a boomerang effect, ultimately resulting in the message
recipient choosing not doing what is being advocated in the message (Witte, 1992).
Therefore, a health campaign message that focuses only on the severity of the threat and
the target population’s susceptibility to it is likely to fail. There must also be a focus on
efficacy.
In the current study, the recommended behavior change is persuading people to
carry Narcan nasal spray (the brand name for the naloxone medication used in the
message) so they are prepared in the event of a loved one overdosing. Therefore, selfefficacy will measure participants’ perception that they themselves can help their loved
ones in an overdose emergency. Likewise, response-efficacy will measure the
participants’ perception that Narcan nasal spray is an effective response to an opioid
overdose.
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Perception of system-efficacy
The current study also considers system-efficacy and how it contributes to
individual behavioral intention. System-efficacy is defined as the belief that the society
one belongs to can provide effective support and/or mitigate harm (Venette, 2008;
Anthony, Venette, Pyle, Boatwright, & Reif, 2018; Macpherson et al., 2014).
Fundamentally, if an individual lacks trust in some part of the system to which they
belong (family or society for example), their lack of trust affects whether or not they
regard or adhere to recommendations advocated by members of the system.
Having a low perception of system-efficacy might stem from several factors
including a belief that an entity within the system (i.e., perceptions of Purdue Pharma
among families dealing with opioid dependence) does not have the best intentions. For
example, the core issue of an individual who questions the practice of vaccinating
children might be their perception that the government or pharmaceutical companies do
not have their best interest in mind. This low perception of system-efficacy might lead
them to reject what is being advocated regardless of any other information or evidence.
Alternatively, people may perceive that an entity may not have the necessary resources to
help. For instance, the core issue of an individual who decides not to call a suicide
prevention hotline may simply believe that the group responding does not have the ability
or resources to help them overcome their situation. In both examples, while different, the
individual does not have faith that the system that they belong to can help them overcome
the threat they are facing. For the current study, system-efficacy will measure the
participants’ belief that first responders, pharmaceutical companies, family members,
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friends, etc., can help mitigate the harm created by the opioid crisis for themselves and
the people around them.
Danger-control response and fear control response
Response, the final concept in the EPPM, is the reaction to the fear appeal.
Message recipients will respond in one of three ways: No response, fear-control response,
or danger-control response (Witte, 1992). If the threat component of the message does
not induce fear in the recipient, he or she will likely have no response to the message,
rendering it ineffective. If the threat component does induce fear, but the recommended
action is not efficacious to the listener, the recipient will likely experience a fear-control
response. When individuals experience a fear-control response, they may rationalize the
threat as not harmful to them. In essence, they are controlling their fear by convincing
themselves that they are not in danger. This may result in individuals avoiding
recommended actions or even concluding that the recommended behavior change is
ineffective.
However, if the threat component of the message induces fear and the
recommended action is perceived as efficacious, the recipient will be more likely to react
with a danger-control response. A danger-control response often results in the message
recipient engaging in the recommended action. Given this response, individuals decide
that they are in real danger and need to act to weaken their susceptibility to the threat.
They realize that they can take precautionary measures by adhering to the recommended
behaviors. In other words, without clear messages promoting self-efficacy and responseefficacy, individuals may attempt to control their fear through rationalization rather than
controlling the actual threat by changing their behavior.
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Figure 3. Extended Parallel Process Model
(Witte, 1992)

Optimistic Bias
Optimistic bias is the tendency for an individual to believe that he or she is less at
risk of a threat than the average person; optimistic bias reveals the ways individual
judgements of risk are subjective (Turner, Skubisz, & Rimal, 2011). For example,
smokers and non-smokers alike believe that other people are more likely die from
smoking cigarettes than they are themselves (Arnett, 2000). Interestingly, subjective
judgements, like the smoking example, nearly always reveal lower—not higher—
individual perceptions of susceptibility (Turner, Skubisz, & Rimal, 2011). Rogers (1998)
argues that humans display optimistic bias not only when considering potentially
negative outcomes (i.e., a greater likelihood that bad things will happen to others instead
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of themselves), but also in considering potentially good outcomes (i.e., a greater
likelihood they could win the lottery over others). The optimist bias phenomenon is
apparent even in populations most at risk. For instance, African American teenagers
report perceiving that they are less likely to become pregnant or cause pregnancy when
being sexually active than the “average person” (Chapin, 2001); however, in actuality,
African American teenagers consistently experience higher than average rates of teen
pregnancy when compared to other demographic groups (HHS, 2019).
Although scholars as early as Lund (1925) investigated individuals’ beliefs about
future events, Weinstein (1980) first fully articulated the optimistic bias phenomenon. In
this first study, when asked about the likelihood of future events, students rated their own
likelihood of experiencing positively valanced events as higher than that of their
classmates. For life events perceived to be negative, the students rated their classmates’
likelihood of experiencing the events as higher than their own. Recently, scholars have
shown that individuals experience optimistic bias with foodborne disease (Rossi,
Stedefeldt, da Cunha, & de Rosso, 2017), investment outcomes (Wu, Liu, Han, & Yin,
2018), high blood pressure and obesity (White et al., 2017), cancer and cardiovascular
disease (Masiero, Riva, Oliveri, Fioretti, & Pravettoni, 2018), bladder cancer (Riva,
Masiero, Mazzocco, & Pravettoni, 2018), and others (see Table 1).
Several explanations have been offered over the years as to why optimistic bias
exists (Turner, Skubisz, & Rimal, 2011), including that optimistic bias serves as a tool to
help alleviate anxiety from more realistic expectations of susceptibility (Kirscht, Haefner,
Kegeles, & Rosenstock, 1966). Additionally, optimistic bias has been explained through
the “Muhammad Ali Effect,” or the idea that “people wish to hold positive beliefs about
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Table 1 Instances of Optimistic Bias found in the Current Literature
Article

Threat

Population

Kim & Hancock, 2015

Negative Social and

Facebook Users

Psychological Outcomes of
Facebook
Park & Ju, 2016

Alzheimer’s Disease

Adults 65 and older

Chapin & Coleman, 2017

Cyberbullying

7th-12th Graders

White, et al., 2017

High Blood Pressure and

African American

Obesity

Adolescents

Foodborne Disease

Food Handlers

Bladder Cancer

Young Adults

Cancer and Cardiovascular

Young Adults

Rossi, Stedefeldt, da
Cunha, & de Rosso, 2017
Riva, Masiero, Mazzocco,
& Pravettoni, 2018
Masiero, Riva, Oliveri,

Fioretti, & Pravettoni, 2018 Disease
Wu, Liu, Han, & Yin, 2018 Investment Outcomes

Analysts

Hwang, et al., 2019

COPD

Male Smokers

Drouin, Winickoff, &

Tobacco Use and Obesity

Parents

Foodborne Disease

Food Handlers and

Thorndike, 2019
Andrade, Rodrigues,
Antongiovanni, & de

Consumers

Cunha, 2019
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themselves. These beliefs are often that they are at least average on important dimensions
and possibly above average” (Allison, Messick, & Goethals, 1989, p. 289). However, a
more recent explanation for optimistic bias posits that when asked to compare ourselves
to others, we often believe that we experience less risk than others for certain negative
consequences (Rimal & Morrison, 2006).
Finally, another recent and simpler explanation is that individuals feel more
positivity about their own behaviors than the behaviors of others (Turner, Skubisz, &
Rimal, 2011). Perhaps another way to understand this explanation is through the
fundamental attribution error, which asserts that humans will blame negative actions of
themselves on external factors while blaming negative actions of others on internal
factors (Ross, 1977). For instance, if a person is asked to compare the likelihood of their
family members dying in an automobile accident and an average family dying in an
automobile accident, he or she might assume that his or her own family would only be in
a car without a seatbelt if they were in a hurry (external explanation), but the average
family would be in the car without a seatbelt because they were irresponsible (internal
explanation). This flawed thinking results in an optimistic bias.
Interestingly, optimistic bias is not a cultural phenomenon; research suggests a
bias towards unrealistic optimism spans across cultures (Peeters, Cammaert, &
Czapinski, 1997; Ji, Zhang, Usborne, & Guan, 2004). North Americans, Argentines, and
Japanese citizens alike reveal an optimistic bias in their perceived risk of experiencing
natural and manmade disasters (Gierlach, Belsher, & Beutler, 2010). Further, Chang,
Asakaw, & Sanna (2001) argued that even cultural groups may share a “pessimistic bias”
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when rating the likelihood of events occurring to other cultural groups. For instance, a
member of ‘group A’ will likely rate the probability of negative events affecting a
member of ‘group B’ much higher than the probability of those same negative events
affecting a member of his own group. Similarly, ‘group B’ participants would probably
rate a member of ‘group A’ as more likely to experience the negative event than a
member of her group.
Given the seemingly pervasive nature of optimistic bias at the individual and
group level, understanding the perceptions of risk among individuals concerning the
involvement of themselves or someone they know in an opioid overdose situation is
central to the current study.
Gain-Frame/Loss-Frame
Another way that message designers can manipulate a message is by using a gainframe/loss-frame technique. “A positive (gain) frame that emphasizes the advantages of
compliance, or a negative (loss) frame that emphasizes the disadvantages of
noncompliance” (O’Keefe & Jensen, 2006, p. 1-2). For example, a gain-frame message
persuading people not to drink soda would emphasize weight loss and increased energy.
A loss-frame message would warn people about diabetes and weight-gain.
In designing messages intended to make audience members consider threats posed
to their loved ones, messages should emphasize advantages or disadvantages for the
loved ones resulting in compliance (or lack of compliance) by the reader. For example, a
campaign targeted at parents encouraging them to set better examples for their children
by exercising more and inviting their children to join with them could either focus on
potential gains (healthier children) or potential losses (juvenile diabetes).
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Not only should message designers be conscious of gain-frame and loss-frame
techniques, but whether the kernel state of the message is a desirable consequence or an
undesirable consequence (O’Keefe & Jensen, 2009). A gain-frame message for instance
can focus on either a desirable consequence or an undesirable consequence. For example,
an anti-smoking campaign can employ a desirable kernel state such as pretty teeth and
good hygiene, or an undesirable kernel state such as lung cancer. In a gain-frame
message, if the undesirable kernel state were chosen, then the gain-frame message would
emphasize the opportunity to avoid lung cancer by quitting smoking, and the loss-frame
message would emphasize the consequence of raising one’s lung cancer likelihood by
continuing to smoke. Therefore, campaign designers have four options to choose from
(gain/desirable, gain/undesirable, loss/desirable, and loss/undesirable) when creating a
message.
One moderating factor that can help message designers determine when to
employ gain-frame or loss-frame deals with whether the recommendation is prevention or
detection-related. O’Keefe and Jensen (2006) found that when specifically talking about
disease, disease prevention messages (i.e., you should eat healthy to avoid obesity)
should employ gain-frame messages. However, when discussing disease detection (i.e.
get your colon checked every ten years to screen for cancer), there is no significant
difference between the two strategies. These framing decisions ultimately impact the
response that message recipients will have toward the recommended behavior. Prospect
theory (Tversky & Kahneman, 1981) for example, explains how people respond to risky
propositions when framed around potential gains as opposed to potential losses. The
theory suggests that if two equal choices are presented to an individual, one focused on
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the potential gains and the other focused on the potential losses, the individual is most
likely to choose the proposal focused on potential gains.
The relationship between efficacy and framing techniques is not crystal clear. For
example, while three separate studies all conclude that the effects of framed-messages are
moderated by self-efficacy, (Van’t Riet, Ruiter, Werrij, & De Vries, 2008; Van’t Riet,
Ruiter, Werrij, & De Vries, 2010; Werrij, Ruiter, Van’t Riet, & De Vries, 2011), two
found a loss-frame advantage for those with high perceptions of self-efficacy (Van’t Riet,
Ruiter, Werrij, & De Vries, 2008; Van’t Riet, Ruiter, Werrij, & De Vries, 2010), and the
third found a gain-frame advantage (Werrij, Ruiter, Van’t Riet, & De Vries, 2011).
For the purposes of the current study, the researcher employed an undesirable
kernel state message in all messages with a gain-frame/loss-frame manipulation. The
messages focus on the advantages or disadvantages that could be experienced by loved
ones of the message recipient resulting directly from his compliance or noncompliance to
the message recommendations. In the context of an opioid overdose, the gain-frame
message focuses on the message recipient’s loved one recovering from an overdose
because of the recipient’s compliance to the message recommendation. The loss-frame
message focuses on the message recipient’s loved one dying because of incompliance to
the message recommendation. This study aims to identify any differences in reported
compliance based on which type of message (gain-frame or loss-frame) is randomly
assigned to each participant.
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Labeling and Stigmatization through Language
The way in which certain message characteristics are framed, such as the names
given to people or objects, can have a significant impact on the way a message is
processed (Dillard & Pfau, 2002). One example of this was an experiment that tested two
versions of descriptive materials to farmers (Menegaki, Mellon, Vrentzou, Koumakis, &
Tsagarakis, 2009). The farmers that read materials that used the name “recycled water”
were more likely to use and pay for the irrigation water than the farmers that read
materials that used the name “treated wastewater.” The clear preference for the term
“recycled water” is directly related to the stigma attached to the term wastewater.
Certain words or phrases carry a negative stigma with them that can change the
way people perceive an issue or individual (Link & Phelan, 2001). For example, referring
to people living in a country without proper documentation as an “illegal aliens” may
create more hostility towards that group of people than if they were referred to as
“undocumented immigrants.” In the medical field, there are many instances of
terminology with attached negative stigma, including HIV-positive (Vanable, Carey,
Blair, & Littlewood, 2006), mental illness (Gaebal, Zaske, & Baumann, 2006), and
obesity (Bombak, McPhail, & Ward, 2016).
Link and Phelan (2001) provided a five-step explanation of the stigmatization
through language process that includes labeling, stereotyping, separation, status loss, and
discrimination. The scholars describe labeling as affixing a name to a person or group of
people based on an identifiable difference. Scholars in disability discourse first described
labeling as a driving force of stigmatization by identifying words like “handicapped” and
“disabled” as potentially harmful (Kailes, 1985; Cortina, 2013). Similarly, the word
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addict has earned a generally negative connotation (Cortina, 2013), with some calling on
scholars and professionals to employ a new term when addressing substance use disorder
patients (Hosea, 2014).
The lack of effort to challenge the word “addict” has enabled its social acceptance
in language without consideration to its role in dehumanizing people experiencing
addiction. In news media, its use by “unbiased” reporters has almost become
habitual. More concerning, however, is the use of “addict” by professionals who
advocate against stigma. Although used naively, messages can become confusing
when elicited stereotypes are incongruent to the larger goal of depicting
addiction’s humanity (Cortina, 2013, p. 105).
The current study aims to identify if the label of “addict” has an impact on an
individual’s perception of susceptibility, severity, and her behavioral intent. The study
will directly consider the impact of the label “addict” in contrast to the label “victim” to
understand which is more influential on perceptions and behavioral intentions.
Linguistic Agency Assignment
Duranti (2004) defines agency as “the property of entities that have some degree
of control over their own behavior” (p. 453). McGlone and Pfiester (2009) revealed that
typically people tend to ascribe agency to themselves in positive situations (i.e., “I did
well on the test.”). Alternatively, individuals are more likely to ascribe agency to external
events or forces in negative situations (i.e., “We lost because my teammates let us
down.”).
However, when agency is assigned linguistically, an entity is ascribed the ability
to act or change within the structure of the statement (Bell, McGlone, & Dragojevic,
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2014). In messages designed to communicate information about health threats, message
designers can structure statements in one of two ways, by assigning linguistic agency to
the threat or to the potential victim (McGlone, Bell, Zaitchik, & McGlynn III, 2013). For
example, McGlynn and McGlone (2018) demonstrated this concept well by assigning
agency in one message to obesity (Obesity develops in men and women equally) and in
another message to humans (Men and women are equally likely to grow obese).
McGlone, Bell, Zaitchik, & McGlynn III (2013) first investigated the effect of
assigning agency linguistically on behavior change. The researchers gave participants one
of two versions of a printed educational handout informing them of the dangers of the
H1N1 virus and the efficacy of the H1N1 vaccine. The first message ascribed agency to
the virus, and the second message ascribed agency to the reader. The results showed that
participants who read the message ascribing agency to the virus reported higher
perceptions of severity and personal susceptibility, as well as a higher intention to get the
H1N1 vaccination.
In addition to obesity (McGlynn & McGlone, 2018) and the H1N1 virus
(McGlone, Bell, Zaitchik, & McGlynn III, 2013), research performed in this area has
tested linguistic agency assignment with a variety of health threats, including harmful
bacteria (Bell, McGlone, & Dragojevic, 2014a), HPV (Bell, McGlone, & Dragojevic,
2014b; Zhang & McGlone, 2018), radon gas (Dragojevic, Bell, & McGlone, 2014), colon
cancer (Chen, McGlone, & Bell, 2015), diabetes (Glowacki, McGlone, & Bell, 2016),
cigarette smoking (Wartel, 2017), and depression (Kahn & Peña, 2017).
Further, individuals may perceive some threats differently than others. For
example, a message about an external threat, such as a virus or bacteria, might be
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processed differently than a message with an internal threat, such as obesity or
depression. Some threats are more easily personified than others as well. For instance, a
living bacterium may seem more frightening when assigned agency than a wildfire that is
not a living entity. Opioids may represent a different type of threat altogether. For
example, one could argue that the pill or the heroin itself is external while addiction is
internal.
Table 2 Linguistic Agency Assignment Findings in Health Communication Literature
Article

Threat

Relevant Findings

McGlone, Bell, Zaitchik,

H1N1

Threat agency led to higher severity and

& McGlynn III, 2013

susceptibility perceptions, as well as higher
behavioral intent.

Bell, McGlone, &

Harmful

Threat agency led to higher severity and

Dragojevic, 2014a

bacteria

susceptibility perceptions.

Bell, McGlone, &

HPV

Threat agency led to higher severity

Dragojevic, 2014b
Dragojevic, Bell, &

perception.
Radon gas

McGlone, 2014

Sentient threat agency led to higher severity
perception.

Chen, McGlone, & Bell,

Colon

Human agency led to higher susceptibility

2015

cancer

perception.

Glowacki, McGlone, &

Diabetes

Threat agency led to higher severity

Bell, 2016

perception.
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Agency can be assigned linguistically to opioid messages in two ways; Threat
(opioid) agency and human agency. For example, a threat agency message could state,
“opioids could kill somebody you love.” A human agency message, on the other hand,
could say, “somebody you love could die from negligent use of opioids.” In the former
message, opioids appear to have control over whether they will kill somebody close to
the message recipient. In that latter message, the recipient’s loved ones seem to have
control over whether opioids will take their life. These small but important distinctions in
sentence structure have been shown to have an effect on message recipients’ perceptions
of threat severity and threat susceptibility (McGlone, Bell, Zaitchik, & McGlynn III,
2013).
Hypotheses and Research Question
EPPM
In the current study, purchasing and using Narcan is argued to be a highly
effective behavior for combatting the opioid crisis. The messages created for the current
study specifically encourage the reader to purchase Narcan. Indirectly, readers may
experience the need to seek more information about Narcan or to use Narcan in the
future. Based on the tenets and structure of the EPPM and message design literature, the
following hypotheses guided analysis of the model.
H1a: Perception of threat severity, perception of susceptibility, perception of selfefficacy, and perception of response-efficacy will positively predict the respondents’
likelihood to accept the discount coupon for Narcan nasal spray.
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H1b: Perception of threat severity, perception of susceptibility, perception of selfefficacy, and perception of response-efficacy will positively predict the respondents’
likelihood of seeking more information about Narcan nasal spray.
H1c: Perception of threat severity, perception of susceptibility, perception of selfefficacy, and perception of response-efficacy will positively predict the respondents’
belief they will own Narcan nasal spray in the future.
Optimistic bias
In the current study, respondents’ optimistic bias toward loved ones overdosing
on opioids is considered. Specifically, the current study measures respondents’ perceived
likelihood of their loved ones overdosing versus the likelihood of the average person
overdosing. Based on the optimistic bias scholarship, the following hypotheses are
posited:
H2: When considering the likelihood of loved ones overdosing on opioids, respondents
will display optimistic bias.
H3a: Optimistic bias concerning loved ones overdosing on opioids will lead to
significantly lower odds of accepting the discount coupon for Narcan.
H3b: Optimistic bias concerning loved ones overdosing on opioids will lead to
significantly lower odds of seeking more information about Narcan.
H3c: Optimistic bias concerning loved ones overdosing on opioids will lead to
significantly lower odds of believing that they will own Narcan in the future.
Gain-frame/loss-frame
It was suspected that gain-frame messages, or those that emphasize the
opportunity to save the lives of friends and family by being equipped with Narcan, and
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loss-frame messages, or those that may emphasize the potential death of friends and
family if not prepared for an overdose emergency, would result in varying behavioral
responses. Based on the message design and Prospect Theory literatures, the following
hypotheses guided the analysis:
H4a: Self-efficacy will be a stronger predictor of behavioral intent for respondents who
receive the gain-frame message than those who receive the loss-frame message.
H4b: Response-efficacy will be a stronger predictor of behavioral intent for respondents
who receive the gain-frame message than those who receive the loss-frame message.
Labeling and stigmatization through language
This study included a linguistic variation on labeling individuals with an opioid
dependence. The manipulation framed individuals in two different ways: addict or victim.
Because of the negative effect stigmatized labeling has on message processing
(Menegaki, Mellon, Vrentzou, Koumakis, & Tsagarakis, 2009), the researcher predicted
that labeling individuals as addicts will result in a lower likelihood to adhere to message
recommendations. Therefore, the following hypotheses are offered:
H5a: The variables of the EPPM (severity, susceptibility, self-efficacy, and responseefficacy) will be stronger predictors of intention to purchase Narcan in the messages
labeling people as “victims” rather than “addicts.”
H5b: The variables of the EPPM (severity, susceptibility, self-efficacy, and responseefficacy) will be stronger predictors of intention to seek information in the messages
labeling people as “victims” rather than “addicts.”
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H5c: The variables of the EPPM (severity, susceptibility, self-efficacy, and responseefficacy) will be stronger predictors of intention to own Narcan in the messages labeling
people as “victims” rather than “addicts.”
Linguistic agency assignment
Based on the linguistic agency literature that shows perceptions of severity and
susceptibility are most often higher when reading threat agentic messages, the following
hypotheses are proposed:
H6a: Severity will be a stronger predictor of behavioral intention for respondents who
receive the threat agency message than those who receive the human agency message.
H6b: Susceptibility will be a stronger predictor of behavioral intention for respondents
who receive the threat agency message than those who receive the human agency
message.
System-efficacy
Self-efficacy and response-efficacy were included in the original EPPM
framework, and these variables have received much scholarly attention. While the
breadth of literature and empirical data concerning system-efficacy are much smaller, the
construct of system-efficacy may offer some additional explanative power for the EPPM,
particularly as individuals consider the greater organizations, entities, or forces at play
that may affect whether a threat can be overcome. For these reasons, the following
hypotheses were included to better understand system-efficacy:
H7: The perception of system-efficacy will positively predict behavioral intent.
H8a: The perception of system-efficacy will be a better predictor of behavioral intent in
gain-frame messages than it will be in loss-frame messages.
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H8b: The perception of system-efficacy will be a better predictor of behavioral intent in
the “victim” group messages than it will be in the “addict” group messages.
H8c: The perception of system-efficacy will be a better predictor of behavioral intent in
threat agentic messages than it will be in human agentic messages.
Unintended interactions
Finally, given the breadth of the current study, there may exist some unintended
main effects or interactions between variables. To identify these instances, the following
research question is posited:
RQ1: Do any significant main effects or interactions exist for the three message
manipulations (gain-frame/loss-frame message manipulation, victim/addict labeling
manipulation, and linguistic assignment of agency).
Summary
This chapter provides an extensive review of existing literature concerning the
EPPM, optimistic bias, and the message-design elements employed in the study (message
framing, labeling, and linguistic agency assignment). Based on the hypotheses offered,
the proposed model for the study is demonstrated visually in figure 4 below. The
following chapter will detail the research methods of the study in-depth.

38

Figure 4. Proposed Model
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CHAPTER III - METHOD
Participants
An a priori power analysis using G*Power version 3.1 was first conducted to
identify the appropriate number of participants. According to the power analysis, 280
respondents were needed to achieve a 90% power for detecting a small to medium-size
effect (0.25) when employing the standard .05 criterion for statistical significance
(Cohen, 1992). Participants were randomly assigned to one of eight message conditions
(see figure 5). Each message was manipulated according to three independent variables:
linguistic agency assignment, gain-frame/loss-frame, and stigmatizing “addict”/nonstigmatizing “victim” labels (Tables 3-5).
For validation purposes, respondents’ IP addresses were used to screen for
duplicate individual responses. Additionally, respondents who completed the survey in
less than 100 seconds were automatically removed from the sample. Finally, one item
was included to check the respondents’ attention to the survey (e.g., I am paying attention
to this survey), and three additional items were included to monitor how closely each
respondent read the message. Participants who did not indicate paying close attention to
the survey or reading the message were removed from the sample.
The minimum age of respondents was 18, and they were required to reside within
the United States at the time of the survey. Participants were recruited through Amazon’s
online crowdsourcing platform, Amazon Mechanical Turk (MTurk), with a $1.00
incentive for participating. MTurk has been recognized as an appropriate data collection
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Figure 5. Message Conditions for Participants

Table 3 Gain-Frame/Loss-Frame Message Conditions
Gain-Frame

Loss-Frame

You can save them!

Your loved ones could be next!

You can help!

The crisis is real…

NARCAN saves lives

NARCAN

immediately saving their life!

he or she will likely die!

… coupon and save a life!

… coupon or you may lose a loved one!

Table 4 Victim/Addict Message Manipulations
Victim

Addict

Opioids addicts…

Victims of the opioid crisis…

63,000 victims

63,000 addicts

Who are the victims?

Who are the addicts?
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Table 5 Linguistic Agency Assignment Message Manipulations
Threat Agency

Human Agency

Opioids are killing people

People are dying

Opioids killed over 63,000 victims

63,000 victims died

People are overdosing

Opioids are killing

NARCAN restores the victim’s breathing

The victim begins breathing

Opioids suffocate

Victim ingests

tool because of its ability to obtain high-quality and demographically diverse samples
(Buhrmester, Kwang, & Gosling, 2011; Sheehan, 2017).
In the early stages of MTurk, scholars questioned the ability of the platform to
provide a true random sample and valid responses. Primarily, researchers were concerned
with the data collection technique as survey respondents tend to miss validity checks
more often and complete surveys more quickly than participants recruited in traditional
ways (Aruguete et al., 2019). To combat this concern, the current study implemented
several validity checks and duration timers, as mentioned above, to monitor respondents
more closely. Second, MTurk respondents are also internet users and may be more
technologically savvy than the actual population. However, despite this potential
difference, the ability of crowdsourcing platforms like MTurk to produce a random
sample of the general population is unmatched by most traditional methods.
Between March 20, 2019 and March 28, 2019, the researcher gathered 388
original responses through MTurk. However, not all responses were included in the final
data set. Using participants’ Internet Protocol (IP) address, the researcher identified 12
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respondents who completed the survey twice. The twelve duplicate responses were
removed from the data. 22 surveys were completed in under two minutes, an amount of
time determined insufficient by the researcher to fully complete the questionnaire, and
these responses were also omitted from the data. Another 23 surveys were not completed
fully and were therefore excluded from the data. Finally, 27 participants responded
unsatisfactorily to attention and reading checks (i.e., they failed to follow basic
commands created to ensure they were playing close attention to the message and
survey); these responses were also deleted. After deleting questionable responses, the
final data set included 304 participants, which was 78.4% of original responses. This
number exceeded the recommendation of the a priori power analysis by 24.
Of the 304 participants, 52.6% (n=160) were male, 46.1% (n=140) were female,
and 1.3% (n=4) reported “other” or did not disclose their biological sex. 78.6% (n=239)
identified as white, 8.2% (n=25) identified as Black or African American, 7.2% (n=22)
identified as Asian, 2.3% (n=7) identified as American Indian or Alaska Native, and
3.6% (n=11) identified as “other.” 15.1% (n=46) of participants identified themselves as
Hispanic. Sex and racial diversity reflected actual population estimates closely (U.S.
Census, 2018), suggesting MTurk to be a useful tool for data collection and random
sampling. Respondents’ ages are reported in table 6. The age group with the most
participants was 25-34. This happens to be the age group with the largest percentage of
opioid overdoses from 2017 (Kaiser Family Foundation, 2019).
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Table 6 Age of Respondents
Age

% (N)

18 - 24

6.9% (n=24)

25 - 34

40.7% (n=124)

35 - 44

29.2% (n=89)

45 - 54

11.5% (n=35)

55 - 64

9.2% (n=28)

65 - 74

2.6% (n=8)

75 or older

0% (n=0)

Data Collection Procedure
After respondents agreed to participate in the study, they were presented with
instructions on the MTurk assignment page. The instructions explained the steps needed
to complete the survey and receive the incentive while also explaining that duplicate
responses would not be accepted. A URL led the participants to a survey on the Qualtrics
website. Once a participant gave informed consent, he or she was randomly assigned to
one of the eight messages about Narcan nasal spray (see Figure 6 for an example and
Appendix B for all eight messages). After reading the message, respondents completed
the accompanying survey questionnaire (Appendix A). After the respondents answered
all questions, they were instructed to type a code of their choosing into a corresponding
dialogue box and to also type the same code into the MTurk assignment page. This code
was used to verify completion of the assignment to provide incentives to participants.
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Figure 6. Message with Victim, Threat Agency, and Gain-Frame Manipulations
Instruments
Validity and reliability
An exploratory factor analysis (EFA) was conducted to assess the validity of the
scales used in this study. EFA is “a widely utilized and broadly applied statistical
technique in the social sciences” (Costello & Osborne, 2005, p. 1). EFA assists scholars
in reducing a set of items into a smaller set of factors, establishing underlying
dimensions, and providing construct validity for self-reporting scales (Williams, Onsman,
& Brown, 2010). For the current study, extraction was based on a fixed number of 5
eigenvalues derived from the theoretical underpinnings of the study variables and
constructs. A principle components analysis (PCA) was employed with a Varimax
rotation. Reliability was determined using a Cronbach’s (1951) coefficient alpha to assess
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the inter-relatedness of the items in each scale. Each variable met the minimally
acceptable reliability standard of 0.70.
Measures
The following section discusses each of the variables used in the study. The
specific items that correlate with the measures discussed here can be found on the full
instrument in Appendix A. Results from the EFA and reliability analyses are also found
in this section.
Perception of threat severity. Perception of severity was measured using a
modified version of a three-item scale used by McGlone, Bell, Zaitchik, & McGlynn III,
(2013) that exhibited high reliability (α=0.82). It was modified to reflect the respondents’
perceptions of whether overdosing on opioids may be a threat to friends and family
members. An additional fourth item was added. Example items for the severity scale
include “Opioids pose a serious risk my loved ones” and “Opioids are a severe threat to
my loved ones.” All items were measured by a six-point Likert type scale ranging from 1
(strongly disagree) to 6 (strongly agree). After reliability analysis, one item was removed
from the scale to increase the final Cronbach’s alpha. Loadings from the EFA and
Cronbach’s alpha are reported in table 7.
Perception of threat susceptibility. Perception of susceptibility was measured
using a modified version of a three-item scale used by McGlone, Bell, Zaitchik, &
McGlynn III, (2013) that exhibited high reliability (α=0.81). It was modified to reflect the
respondents’ perception that their loved ones are susceptible to the opioid crisis. An
additional fourth item was added. Example items for the susceptibility scale include “It is
possible that one of my loved ones will overdose on opioids” and “I believe that one of
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my loved ones could be a victim of the opioid crisis.” All items were subjected to a sixpoint Likert type scale ranging from 1 (strongly disagree) to 6 (strongly agree). Loadings
from the EFA and Cronbach’s alpha are reported in table 8.
Perception of self-efficacy. Perception of self-efficacy was measured using a
modified version of a three-item scale used by McGlone, Bell, Zaitchik, & McGlynn III,
(2013) that exhibited high reliability (α=0.82). The self-efficacy scale was modified to
reflect the respondents’ perceptions of whether they have the personal ability to
successfully use Narcan. An additional fourth item was added. Example items for the
self-efficacy scale include “Narcan nasal spray is easy to use” and “There is nothing
preventing me from successfully using Narcan nasal spray.” All items were subjected to a
six-point Likert type scale ranging from 1 (strongly disagree) to 6 (strongly agree). After
reliability analysis, one item was removed from the scale in order to increase the final
Cronbach’s alpha. Loadings from the EFA and Cronbach’s alpha are reported in table 9.
Perception of response-efficacy. Perception of response-efficacy was measured
using a modified version of a three-item scale used by McGlone, Bell, Zaitchik, &
McGlynn III, (2013) that exhibited high reliability (α=0.77). The response-efficacy scale
was modified to reflect the respondents’ perceptions of whether Narcan is believed to be
an effective remedy for opioid overdose experiences. An additional fourth item was
added. Example items for the response-efficacy scale include “Narcan nasal spray will
prevent the death of a loved one who has overdosed” and “Narcan nasal spray is effective
in ending the threat of a friend or family member dying from an overdose.” All items
were subjected to a six-point Likert type scale ranging from 1 (strongly disagree) to 6
(strongly agree). Loadings from the EFA and Cronbach’s alpha are reported in table 10.
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Perception of system-efficacy. A four-item scale was created to measure systemefficacy. The system-efficacy scale was built to reflect the respondents’ perceptions of
how well the system that they belong to protects their loved ones from the opioid crisis.
Example items for the system-efficacy scale include “I believe there are organizations or
agencies that want to protect me from the opioid crisis” and “Pharmaceutical researchers
and scientists want to protect me from the opioid crisis.” All items were subjected to a
six-point Likert type scale ranging from 1 (strongly disagree) to 6 (strongly agree).
Loadings from the EFA and Cronbach’s alpha are reported in table 11.
Table 7 Validity and Reliability for Perception of Threat Severity Scale
Item

EFA Factor
Loading

Opioids pose a serious risk to my loved ones.

0.52

Opioids are potentially harmful to my loved ones.

0.66

Opioids are a severe threat to my loved ones.

0.61

Note: Cronbach’s alpha was 0.91

Table 8 Validity and Reliability for Perception of Threat Susceptibility Scale
Item

EFA Factor
Loading

My loved ones are at risk for being an opioid overdose victim.

0.89

It is possible that one of my loved ones will overdose on opioids.

0.91

I believe that one of my loved ones could be a victim of the opioid crisis.

0.92

An opioid overdose could happen to one of my loved ones.

0.91

Note: Cronbach’s alpha was 0.95
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Table 9 Validity and Reliability for Perception of Self-Efficacy Scale
Item

EFA
Factor
Loading

Narcan nasal spray is easy to use

0.68

There is nothing preventing me from successfully using Narcan nasal spray.

0.85

I have the ability to use Narcan nasal spray if required.

0.83

Note: Cronbach’s alpha was 0.82

Table 10 Validity and Reliability for Perception of Response-Efficacy Scale
Item

EFA
Factor
Loading

Narcan nasal spray will prevent the death of a loved one who has

0.73

overdosed.
My loved ones are less likely to die from an overdose if I have Narcan nasal

0.77

spray.
Narcan nasal spray is effective in ending the threat of a loved one dying

0.79

from an overdose.
If someone has overdosed on opioids, I believe Narcan nasal spray can save
them.
Note: Cronbach’s alpha was 0.83
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0.83

Table 11 Validity and Reliability for Perception of System-Efficacy Scale
Item

EFA
Factor
Loading

I believe there are organizations or agencies that want to protect me from

0.40

the opioid crisis.
The government will help me respond to the opioid crisis.

0.79

My friends and family will protect me from the opioid crisis.

0.76

Pharmaceutical researchers and scientists want to protect me from the

0.68

opioid crisis.
Note: Cronbach’s alpha was 0.73

Optimistic bias. In order to calculate an individual score for optimistic bias, this
study followed a three-step process. First, respondents were asked “What are the odds
that one of your loved ones will overdose on opioids or heroin?” Answers were collected
on an 11-point scale ranging from “0 = not likely at all” to “10 = extremely likely.”
Second, respondents were asked “What are the odds that the average person will
overdose on opioids or heroin?” The same 11-point scale was used. Finally, the
difference between the two scores was used for each respondent, representing their
optimistic bias score.
Accept Code. Respondents were asked if they would like a 75% off coupon for
Narcan nasal spray at the end of the survey. Their response to this offer (‘yes’ or ‘no’)
was used as a dependent measure of behavioral intent.
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Intent to Own. A second measure of behavioral intent, respondents were also
asked if they think they will ever own Narcan nasal spray in the future. The difference
between this dependent variable and the dependent variable “Accept Code”, is urgency.
Those who wish to purchase now, or soon, will be more likely to accept the discount
code. Those who intend to purchase, but not necessarily in the near future, may indicate
intent to own but refuse the discount offer.
Intent to Seek Information. Finally, for a third behavioral intent dependent
variable, participants were asked if they plan on seeking more information about opioids
or Narcan nasal spray. Their response to this item, “Accept Code”, and “Intent to Own”
were used to measure behavioral intent. The three items were used independently from
each other in the analysis.
Correlates. A series of items were used to measure anticipated extraneous
variables. These items included “Have you ever owned Narcan nasal spray?”, “Have you
ever used Narcan nasal spray?”, “Has someone close to you ever overdosed on opioids or
heroin?", “Before taking this survey, did you know what Narcan nasal spray was?", and
“How familiar were you with Narcan nasal spray prior to taking this survey?”
Table 12 Means and Standard Deviations of Variables and Correlates
Item

M

SD

Optimistic Bias

1.41

2.51

Perception of Severity

3.80

1.41

Perception of Susceptibility

3.49

1.43

Perception of Self-Efficacy

4.67

0.95
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Table 12 Continued
Perception of Response-efficacy

4.72

0.87

Perception of System-efficacy

4.11

0.94

Accept Discount Code

0.32

0.47

Belief of Owning Narcan Nasal Spray in the Future

2.13

0.88

Intention to Seek Information (Yes or No)

0.41

0.49

Intention to Seek Information (Likelihood Scale)

3.75

2.12

Has Owned Narcan Before

1.46

0.93

Has Used Narcan Before

1.48

0.93

Has Experienced Someone Close Overdose

1.82

1.23

Has Prior Knowledge about Narcan

2.53

1.28

Is Familiar with Narcan

2.43

1.34

Data Analysis
Missing data
Because of the small frequency of missing data, mean imputation was employed
to replace the missing values. This technique is frequently used (Batista & Monard,
2003), and mean imputation often performs better than other methods such as multiple
imputation and random selection (Shrive, Stuart, Quan, & Ghali, 2006) because of its
“attractive balance of both accuracy and conceptual simplicity” (p. 9).
Assumptions
The standard skewness value of ±2, and the standard kurtosis value of ±3 were
not met for any of the variables tested (Field, 2013). However, in datasets with large
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sample sizes, violating normality has a very small and often insignificant impact on the
analysis (Tabachnick & Fidell, 2012; Joanes & Gill, 1998). KMO and Bartlett’s Test of
Sphericity revealed a KMO score of .883 while the Bartlett’s Test of Sphericity was
significant (p<.001). The high KMO value indicated that the sample was adequate, and
the significance of Bartlett’s Test of Sphericity revealed that the assumption of sphericity
was met. Finally, assumptions of linearity were tested by graphing the relationships
among relevant study variables, revealing appropriate linear relationships. The
assumption of multicollinearity was met as all tolerance values were above the standard
of 0.2 (Field, 2013).
Table 13 Collinearity Statistics
Item

Tolerance

VIF

Optimistic Bias

.786

1.27

Perception of Severity

.398

2.51

Perception of Susceptibility

.363

2.75

Perception of Self-Efficacy

.784

1.28

Perception of Response-efficacy

.669

1.50

Perception of System-efficacy

.716

1.40

Structural Equation Modeling
Using AMOS 24.0, SEM was conducted to address the hypotheses and research
questions. SEM is “a statistical methodology that takes a confirmatory (i.e., hypothesistesting) approach to the analysis of a structural theory bearing on some phenomenon”
(Byrne, 2016, p. 3). Typically, SEM includes the items for each structure in the model. In
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this study, an EFA was conducted prior to building the model, and the resulting
constructs were employed. Byrne (2016) argues SEM accomplishes four tasks that
separate it from other multivariate procedures. First, its confirmatory approach provides
better inferential analysis that makes hypothesis testing easier. Second, SEM provides
explicit estimates of error that minimize inaccuracies. Third, SEM can incorporate
unobserved or latent variables within a model. Fourth, SEM easily models multivariate
relations.
Once the proposed model (figure 4) was constructed, several fit-indices measured
how well the data fit the model. Normal fit index (NFI) indicates the fit relative to the
null model (Kenny, 2015) Comparative fit index (CFI) is not sensitive to sample size and
compares the fit of the target model to the fit of an independent model (Kenny, 2015).
Incremental fit index (IFI) is analogous to R2 (Kenny, 2015). Finally, the root-mean
square error of approximation (RMSEA) was used, as it is an absolute measure of fit
dependent on the non-centrality parameter (Kenny, 2015).
In the proposed model, optimistic bias, severity, and susceptibility were covaried
because of their theoretical relationship to threat perception. Self-efficacy, responseefficacy, and system-efficacy were also covaried because of their theoretical relationship
with to efficacy perception. The proposed model also controlled for all demographics,
including age, sex, ethnicity, and gender. Each of the demographics were covaried with
one another. Finally, the five correlates, including one’s familiarity with Narcan, whether
an individual has owned Narcan, whether an individual has used Narcan, whether he or
she has prior knowledge of Narcan, and whether he or she has experience with an
overdose event were controlled for and covaried to one another. The fit indices for the
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proposed model are shown in table 14, with the covariance estimates in table 15, and the
regression weights in table 16.
Table 14 Fit Indices for the Proposed Model
Index

Result

NFI

.875

IFI

.915

CFI

.912

RMSEA

.077

Table 15 Covariance Estimates for the Proposed Model
Variables

Estimate

S.E.

C.R.

p

Age2534

<-->

Age1824

-.028

.007

-3.828

<.001*

Age1824

<-->

Age3544

-.020

.007

-2.998

.003*

Age1824

<-->

Age4554

-.008

.005

-1.699

.089

Age1824

<-->

Age5564

-.006

.004

-1.502

.133

Age2534

<-->

Age3544

-.119

.015

-8.181

<.001*

Age2534

<-->

Age4554

-.047

.009

-4.979

<.001*

Age2534

<-->

Age5564

-.037

.008

-4.437

<.001*

Age3544

<-->

Age4554

-.033

.009

-3.926

<.001*
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Table 15 Continued
Age3544

<-->

Age5564

-.027

.008

-3.486

<.001*

Age4554

<-->

Age5564

-.011

.005

-1.983

.047*

Female

<-->

Hispanic

.000

.010

-.006

.995

Female

<-->

Black

.015

.008

1.881

.060

Female

<-->

Asian

.000

.007

-.044

.965

Female

<-->

White

.003

.012

.234

.815

Hispanic

<-->

Black

.017

.006

2.982

.003*

Hispanic

<-->

Asian

-.004

.005

-.834

.404

Hispanic

<-->

White

-.033

.009

-3.846

<.001*

Black

<-->

Asian

-.006

.004

-1.448

.148

Black

<-->

White

-.064

.007

-8.682

<.001*

Asian

<-->

White

-.057

.007

-8.234

<.001*

Age1824

<-->

Female

.001

.007

.163

.870

Age1824

<-->

Hispanic

.003

.005

.506

.613

Age1824

<-->

Black

-.002

.004

-.593

.553

Age1824

<-->

Asian

.008

.004

2.152

.031*

Age1824

<-->

White

-.002

.006

-.289

.772

Age2534

<-->

Female

-.052

.014

-3.636

<.001*

Age2534

<-->

Hispanic

.020

.010

1.977

.048*

Age2534

<-->

Black

.003

.008

.355

.723

Age2534

<-->

Asian

.003

.007

.475

.635
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Age2534

<-->

White

-.022

.012

-1.858

.063

Age3544

<-->

Female

.017

.013

1.295

.195

Age3544

<-->

Hispanic

.002

.009

.263

.792

Age3544

<-->

Black

.006

.007

.781

.435

Age3544

<-->

Asian

-.001

.007

-.204

.838

Age3544

<-->

White

.000

.011

-.010

.992

Age4554

<-->

Female

.016

.009

1.767

.077

Age4554

<-->

Hispanic

-.014

.007

-2.156

.031*

Age4554

<-->

Black

.000

.005

.086

.932

Age4554

<-->

Asian

-.002

.005

-.364

.716

Age4554

<-->

White

.002

.007

.201

.841

Age5564

<-->

Female

.010

.008

1.247

.212

Age5564

<-->

Hispanic

-.007

.006

-1.167

.243

Age5564

<-->

Black

-.004

.005

-.933

.351

Age5564

<-->

Asian

-.007

.004

-1.540

.124

Age5564

<-->

White

.016

.007

2.379

.017*

OptimisticBias

<-->

Susceptibility

-1.526

.223

-6.854

<.001*

SelfEfficacy

<-->

SystemEfficacy

.209

.053

3.962

<.001*

PriorKnowledge <-->

Familiarity

1.284

.122

10.481

<.001*

Familiarity

<-->

Experienced

.483

.087

5.544

<.001*

Familiarity

<-->

EverUsed

.518

.077

6.711

<.001*
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Familiarity

<-->

EverOwned

.491

.076

6.433

<.001*

PriorKnowledge <-->

Experienced

.357

.081

4.384

<.001*

PriorKnowledge <-->

EverUsed

.217

.069

3.138

.002*

PriorKnowledge <-->

EverOwned

.233

.069

3.375

<.001*

Experienced

<-->

EverUsed

.376

.061

6.134

<.001*

Experienced

<-->

EverOwned

.426

.062

6.851

<.001*

EverUsed

<-->

EverOwned

.712

.064

11.109

<.001*

SelfEfficacy

<-->

ResponseEfficacy .382

.052

7.298

<.001*

SystemEfficacy

<-->

ResponseEfficacy .359

.051

6.991

<.001*

OptimisticBias

<-->

Severity

-.954

.210

-4.549

<.001*

Susceptibility

<-->

Severity

1.529

.145

10.571

<.001*

S.E.

C.R.

p

Table 16 Regression Weights for the Proposed Model
Path

Estimate

System-efficacy → Intent to Seek

.271

.121

2.236

.025*

System-efficacy → Accept Code

.041

.027

1.531

.126

System-efficacy → Intent to Own

-.058

.044

-1.318

.187

Response-efficacy → Intent to Seek

.018

.143

.128

.898

Response-efficacy → Accept Code

-.004

.032

-.127

.899

Response-efficacy → Intent to Own

.110

.052

2.103

.035*

Self-efficacy → Intent to Seek

-.012

.122

-.097

.922
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Self-efficacy → Accept Code

-.013

.027

-.483

.629

Self-efficacy → Intent to Own

.062

.044

1.398

.162

Susceptibility → Intent to Seek

.388

.119

3.257

.001*

Susceptibility → Accept Code

.052

.026

1.988

.047*

Susceptibility → Intent to Own

.157

.044

3.604

<.001*

Severity → Intent to Seek

.237

.113

2.094

.036*

Severity → Accept Code

-.018

.025

-.702

.483

Severity → Intent to Own

-.004

.041

-.106

.916

Optimistic Bias → Intent to Seek

-.038

.045

-.835

.404

Optimistic Bias → Accept Code

.006

.010

.564

.572

Optimistic Bias → Intent to Own

.013

.017

.756

.450

Familiarity → Intent to Seek

.125

.130

.966

.334

Familiarity → Accept Code

.042

.029

1.455

.146

Familiarity → Intent to Own

.071

.047

1.505

.132

Prior Knowledge → Intent to Seek

-.134

.125

-1.071

.284

Prior Knowledge → Accept Code

-.022

.028

-.778

.437

Prior Knowledge → Intent to Own

.009

.046

.201

.841

Overdose Experience → Intent to Seek

-.078

.108

-.724

.469

Overdose Experience → Accept Code

.032

.024

1.340

.180

Overdose Experience → Intent to Own

.059

.039

1.509

.131

Ever Used → Intent to Seek

.046

.201

.229

.819

59

Table 16 Continued
Ever Used → Accept Code

.125

.044

2.827

.005*

Ever Used → Intent to Own

.074

.073

1.005

.315

Ever Owned → Intent to Seek

.234

.202

1.160

.246

Ever Owned → Accept Code

.043

.045

.961

.337

Ever Owned → Intent to Own

.340

.074

4.596

<.001*

White → Intent to Seek

.117

.461

.253

.800

White → Accept Code

.083

.102

.818

.413

White → Intent to Own

.043

.169

.254

.800

Asian → Intent to Seek

.229

.592

.388

.698

Asian → Accept Code

.175

.131

1.335

.182

Asian → Intent to Own

.106

.216

.491

.623

Black → Intent to Seek

.721

.565

1.275

.202

Black → Accept Code

.117

.125

.936

.349

Black → Intent to Own

.009

.207

.042

.967

Hispanic → Intent to Seek

-.037

.306

-.119

.905

Hispanic → Accept Code

.076

.068

1.125

.261

Hispanic → Intent to Own

-.029

.112

-.260

.795

Female → Intent to Seek

.314

.215

1.462

.144

Female → Accept Code

.067

.047

1.419

.156

Female → Intent to Own

.207

.078

2.642

.008*

Age 55-64 → Intent to Seek

.249

.719

.346

.729
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Age 55-64 → Accept Code

-.080

.159

-.501

.617

Age 55-64 → Intent to Own

-.212

.263

-.808

.419

Age 45-54 → Intent to Seek

-.046

.704

-.065

.948

Age 45-54 → Accept Code

-.275

.155

-1.768

.077

Age 45-54 → Intent to Own

-.225

.257

-.873

.383

Age 35-44 → Intent to Seek

.071

.666

.107

.915

Age 35-44 → Accept Code

-.203

.147

-1.380

.167

Age 35-44 → Intent to Own

-.113

.244

-.466

.641

Age 18-24 → Intent to Seek

-.132

.275

-.478

.633

Age 18-24 → Accept Code

-.343

.166

-2.060

.039*

Age 18-24 → Intent to Own

-.345

.753

-.458

.647

Age 25-34 → Intent to Seek

-.100

.243

-.412

.680

Age 25-34 → Accept Code

-.179

.147

-1.223

.221

Age 25-34 → Intent to Own

-.134

.665

-.201

.840

Once the proposed model was tested, the researcher adjusted the model by
following the modification indices, covariance estimates, and regression weights.
Optimistic bias was removed from the model because it was not a predictor of any
behavioral intent variable and because the model fit increased upon its removal. Kenny
(2011) suggests that this type of model trimming is appropriate if there is theoretical
justification for doing so. Because optimistic bias is not a theoretical construct of the
EPPM, its exclusion was validated. Similarly, all demographic controls with the
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exception of gender were removed from the model as they were not significant predictors
of behavioral intent. Their removal increased the model fit. Three of the five correlates
were also removed from the model, including prior knowledge, experience with an
overdose event, and prior use. These were removed because of their inability to predict
behavioral intent
The SEM modification indices recommended covarying the following sets of
variables that were not originally covaried: 1) Severity and Ever Owned, 2) Severity and
System-Efficacy, 3) Susceptibility and Ever Owned, 4) Susceptibility and SystemEfficacy, and 5) System-Efficacy and Ever Owned. The remaining pairs of variables that
were covaried in the proposed model remained significant and covaried in the final model
(shown in figure 7). Fit indices (see table 17) covariance estimates (see table 18) and
maximum likelihood estimates (see table 19) are reported. All fit indices indicated the
data fit the model as the NFI, IFI, and CFI were all above .95 and the RMSEA was below
.06 (Hooper, Coughlan, & Mullen, 2008).
The researcher created six groups corresponding to the model to test the
hypotheses. These groups include a gain-frame group, a loss-frame group, a threat agency
group, a human agency group, a victim label group, and an addict label group. Estimates
within each group were compared to the corresponding groups based on the hypotheses.
To conclude chapter three, this study was designed to test messages intended to persuade
respondents to purchase Narcan nasal spray using the EPPM as a theoretical framework.
The resulting survey data were used to address the study’s guiding hypotheses and
research question. These results are found in chapter four, and implications are discussed
further in chapter five.
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Table 17 Fit Indices for Final Model
Index

Result

NFI

.954

IFI

.982

CFI

.982

RMSEA

.044

Table 18 Covariance Estimates for the Final Model
Variables

Estimate

S.E.

C.R.

Severity <--> Susceptibility

1.529

.145

10.57 <.001*

Severity <--> System-efficacy

.358

.070

5.028 <.001*

Severity <--> Ever Owned

.255

.070

3.627 <.001*

Susceptibility <--> System-efficacy

.286

.071

4.028 <.001*

Susceptibility <--> Ever Owned

.378

.073

5.175 <.001*

Self-Efficacy <--> System-efficacy

.194

.049

3.947 <.001*

Self-Efficacy <--> Response-efficacy

.382

.052

7.298 <.001*

Response-efficacy <--> System-efficacy

.349

.048

7.237 <.001*

System-efficacy <--> Ever Owned

.207

.043

4.816 <.001*

Ever Owned <--> Familiarity

.402

.068

5.865 <.001*
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p

Figure 7. Final Model
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CHAPTER IV – ANALYSIS
Chapter IV begins with analyses addressing the hypotheses posited in chapter II,
followed by analysis responding to RQ1. The sections in this chapter correlate to each
hypothesis and research question.
Hypothesis Testing
Hypothesis 1a
Hypothesis 1a stated that perception of 1.) severity, 2.) susceptibility, 3.) selfefficacy, and 4.) response-efficacy would positively predict the respondents’ likelihood to
accept the discount coupon code for Narcan nasal spray. This hypothesis was only
partially supported because not all variables were significant predictors of participants
accepting the code. Specifically, severity, self-efficacy, and response-efficacy did not
significantly predict coupon code acceptance. However, susceptibility was a significant
predictor of code acceptance in the overall model (β = 0.06, SE = 0.02, p <.001). Twenty
percent of the variance is accounted for by susceptibility (R2=0.20). Specifically, for
every increase of a unit of susceptibility, there was a 0.064 unit increase in participants’
code acceptance. Therefore, of the four EPPM predicting variables, only high perceptions
of susceptibility predicted discount code acceptance.
Hypothesis 1b
Hypothesis 1b stated that perception of 1.) severity, 2.) susceptibility, 3.) selfefficacy, and 4.) response-efficacy would positively predict the respondents’ likelihood of
seeking more information about Narcan nasal spray. This hypothesis was also only
partially supported. Both severity (β = 0.25, SE = 0.10, p=.014) and susceptibility (β =
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0.46, SE = 0.11, p < .001) significantly predicted intent to seek more information; neither
self-efficacy nor response-efficacy significantly predicted the intent to seek more
information. Twenty-six percent of the variance was explained by susceptibility and
severity (R2=0.26). For every unit increase in perceived severity, there was a 0.25 unit
increase in one’s intent to seek information. Similarly, for every unit increase in
susceptibility, there was a 0.46 unit increase in intent to seek information. Therefore, a
high threat perception predicted intent to seek more information and a high efficacy
perception did not.
Hypothesis 1c
Hypothesis 1c stated that, perception of 1.) severity, 2.) susceptibility, 3.) selfefficacy, and 4.) response-efficacy would positively predict the respondents’ belief they
will own Narcan nasal spray in the future. This hypothesis was also only partially
supported as two of the four variables were not significant predictors. Specifically,
susceptibility (β = 0.17, SE = 0.03, p<.001) and response-efficacy (β = 0.13, SE = 0.04,
p<.001) were significant predictors of one’s intent to own Narcan, while severity and
self-efficacy were not significant predictors. Thirty-eight percent of the variance was
explained by susceptibility and response-efficacy (R2=0.38). For every unit increase in
perceived susceptibility, there was a 0.17 unit increase in one’s intent to own. For every
unit increase in response-efficacy, there was a 0.13 unit increase in intent to own.
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Table 19 SEM Final Model Maximum Likelihood Estimates
Path

Estimate

S.E.

C.R.

p

Susceptibility → Accept Code

.064

.017

3.650 <.001*

System-efficacy → Accept Code

.053

.024

2.214

Ever Owned → Accept Code

.149

.026

5.859 <.001*

Severity → Intent to Seek

.251

.102

2.460

Susceptibility → Intent to Seek

.461

.105

4.367 <.001*

System-efficacy → Intent to Seek

.355

.107

3.311 <.001*

Susceptibility → Intent to Own

.173

.028

6.224 <.001*

Response-efficacy → Intent to Own

.133

.038

3.479 <.001*

Female → Intent to Own

.132

.065

2.030

Ever Owned → Intent to Own

.376

.042

8.886 <.001*

Familiarity → Intent to Own

.062

.026

2.393

.027*

.014*

.042*

.017*

Hypothesis 2
Hypothesis 2 stated that when considering the likelihood of loved ones
overdosing on opioids, respondents will display optimistic bias. This hypothesis was
supported as there was a significant difference (t=9.808, p<.001, d=0.54) between the
perceived likelihood of loved ones overdosing (M=3.93, SD=2.84) and the perceived
likelihood of external others overdosing (M=5.34, SD=2.40). The results indicate a
medium effect size according to Cohen’s (1992) suggested standards.
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Hypothesis 3a
Because the variable optimistic bias was removed from the overall model, a
separate regression analysis was conducted for hypotheses 3a-3c. Hypothesis 3a stated
that optimistic bias concerning loved ones overdosing on opioids would lead to
significantly lower odds of respondents accepting the discount coupon for Narcan. This
hypothesis was supported as the model was significant (F(1,303)=7.141, p<.008, R2=.02).
Optimistic bias was a significant predictor of accepting the discount coupon (β=-.028,
p=.008). Specifically, for every unit of optimistic bias, a participant was .028 units less
likely to accept the code.
Hypothesis 3b
Hypothesis 3b stated that optimistic bias concerning loved ones overdosing on
opioids would lead to significantly lower odds of seeking more information about
Narcan. This hypothesis was supported (F(4,300)=11.759, p < .001, R2=.14). Optimistic
bias was a significant predictor of a person’s intent to seek information (β=-.132,
p=.006). Specifically, for every unit increase in optimistic bias, there was a 0.132 unit
decrease in intent to seek information concerning Narcan. Additionally, previous
ownership of Narcan (β=.567, p<.001) significantly increased one’s intent to seek
information by 0.567 units. Certain demographic characteristics were also more
significant predictors than others. For instance, being African American (β=.962, p=.022)
significantly increased one’s intent to seek information by 0.962 units. Being female
(β=.563, p=.016) significantly increased intent to seek by 0.563 units.
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Hypothesis 3c
Hypothesis 3c stated that optimistic bias concerning loved ones overdosing on
opioids would lead to significantly lower odds of respondents believing they will own
Narcan in the future. This hypothesis was supported as the model was significant
(F(1,303)=15.213, p<.001, R2=.05). Optimistic bias was a significant predictor of
respondent’s belief that they will own Narcan in the future (β=-.077, p <.001).
Specifically, for every unit increase in optimistic bias, there is a 0.077 unit decrease in
intent to own Narcan.
Hypothesis 4a
Hypothesis 4a stated that self-efficacy would be a stronger predictor of behavioral
intent for respondents receiving the gain-frame message than those receiving the lossframe message. Self-efficacy was not a significant predictor in either the gain-frame
group or the loss-frame group. Therefore, to distinguish between the groups, an
independent samples t-test was conducted. The test was not significant (t=1.207, p=.228)
as the gain-frame group (M=4.74, SD=0.96) did not lead to significantly higher selfefficacy scores than the loss frame group (M=4.60, SD=0.94). As a result, hypothesis 4a
was not supported.
Hypothesis 4b
Hypothesis 4b stated that response-efficacy would be a stronger predictor of
behavioral intent for respondents receiving the gain-frame message over those receiving
the loss-frame message. Response-efficacy was only a predictor of one behavioral intent
variable (intent to own Narcan nasal spray in the future). The hypothesis was not
supported. In fact, the opposite of what was predicted occurred. Response-efficacy was a
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predictor of intent to own in the loss-frame group (β = 0.64, SE = 0.06, p = .005,
R2=0.39), but not in the gain-frame group (β = 0.91, SE = 0.05, p = .077, R2=0.37). The
results for gain-frame and loss-frame groups are presented in table 20.
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Table 20 Gain-Frame and Loss-Frame Group Results
Path

Estimate

S.E.

C.R.

p

Susceptibility →Accept Code

.041

.023

1.792

.073

System-efficacy →Accept Code

.035

.032

1.095

.273

Ever Owned →Accept Code

.211

.032

6.527 <.001*

Severity →Intent to Seek

.195

.149

1.313

.189

Susceptibility → Intent to Seek

.333

.154

2.161

.031*

System-efficacy → Intent to Seek

.441

.141

3.123

.002*

Susceptibility → Intent to Own

.157

.037

4.288 <.001*

Response-efficacy → Intent to Own

.091

.051

1.769

Ever Owned → Intent to Own

.344

.053

6.558 <.001*

Familiarity → Intent to Own

.089

.036

2.506

.012*

Female → Intent to Own

.093

.085

1.093

.274

Susceptibility → Accept Code

.094

.026

3.589 <.001*

System-efficacy → Accept Code

.064

.036

1.796

.072

Ever Owned → Accept Code

.075

.040

1.869

.062

Severity → Intent to Seek

.332

.136

2.444

.015*

Susceptibility → Intent to Seek

.570

.142

4.027 <.001*

System-efficacy → Intent to Seek

.317

.158

2.011

Susceptibility → Intent to Own

.193

.043

4.527 <.001*

Gain-Frame

.077

Loss-Frame
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.044*
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Response-efficacy → Intent to Own

.160

.056

2.835

Ever Owned → Intent to Own

.401

.069

5.847 <.001*

Familiarity → Intent to Own

.048

.037

1.297

.195

Female → Intent to Own

.150

.098

1.538

.274

.005*

Hypothesis 5a
Hypothesis 5a stated that the variables of the EPPM (severity, susceptibility, selfefficacy, and response-efficacy) would be stronger predictors of intent to accept the
discount code for Narcan in the messages labeling people as “victims” rather than
“addicts.” Because susceptibility was the only EPPM variable that significantly predicted
Narcan code acceptance in the overall model, it was the only variable tested in this
hypothesis. Regardless, the hypothesis was not supported; when comparing the regression
weights for the two groups, the results were nearly the same for the victim label (β =
0.06, SE = 0.02, p=.010, R2=0.15) as they were for the addict label (β = 0.07, SE = 0.03,
p=.008, R2=0.24).
Hypothesis 5b
Hypothesis 5b stated that the variables of the EPPM (severity, susceptibility, selfefficacy, and response-efficacy) would be stronger predictors of intent to seek
information in the messages labeling people as “victims” over messages labeling them
“addicts.” Because severity and susceptibility were the only EPPM variables that
significantly predicted intent to seek in the overall model, they were the only variables
tested for this hypothesis. Regarding severity, the hypothesis was supported. Severity was
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a significant predictor of intent to seek more information in the message labeling people
“victims” (β = 0.30, SE = 0.15, p=.036, R2=0.28) and was not a predictor in the message
labeling people “addicts” (β = 0.20, SE = 0.14, p=.172, R2=0.25). With susceptibility, the
hypothesis was not supported. Although the regression weights were very close between
the two groups, susceptibility was a better predictor in the addict message (β = 0.46, SE =
0.14, p=.001, R2=0.25) than it was the victim message (β = 0.45, SE = 0.16, p=.004,
R2=0.28). However, the differences are too small to interpret anything meaningful from
this finding. Therefore, the hypothesis was only supported regarding the perception of
severity.
Hypothesis 5c
Hypothesis 5c stated that the variables of the EPPM (severity, susceptibility, selfefficacy, and response-efficacy) would be stronger predictors of intent to own Narcan in
the messages labeling people as “victims” rather than “addicts.” This time, only
susceptibility and response-efficacy were employed to test the hypothesis because they
were the only significant predictors of intent to own Narcan in the overall model.
Susceptibility was a significant predictor of intent to own Narcan regardless of how
people were labeled. The estimate was slightly higher, albeit not in a statistically
meaningful way, in the “addict”-labeled message (β = 0.17, SE = 0.04, p<.001, R2=0.42)
than it was the “victim”-labeled message (β = 0.17, SE = 0.04, p<.001, R2=0.33).
For response-efficacy, there was a significant difference between labels, but
opposite to what was predicted. Response-efficacy was a significant predictor of intent to
own Narcan in the group receiving the “addict” message (β = 0.18, SE = 0.05, p<.001,
R2=0.42), but response-efficacy was not a predictor in the group receiving the “victim”
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message (β = 0.08, SE = 0.05, p=.152, R2=0.33). Therefore, the hypothesis was not
supported, but the finding for response-efficacy was meaningful. The results of the
victim/addict labeling models are included in table 21.
Table 21 Victim Label and Addict Label Group Results
Path

Estimate

S.E.

C.R.

p

Susceptibility →Accept Code

.061

.024

2.568

.010*

System-efficacy →Accept Code

.056

.032

1.786

.074

Ever Owned →Accept Code

.117

.037

3.142

.002*

Severity →Intent to Seek

.303

.145

2.098

.036*

Susceptibility → Intent to Seek

.447

.155

2.878

.004*

System-efficacy → Intent to Seek

.305

.149

2.043

.041*

Susceptibility → Intent to Own

.166

.040

4.147 <.001*

Response-efficacy → Intent to Own

.078

.054

1.432

Ever Owned → Intent to Own

.418

.065

6.470 <.001*

Familiarity → Intent to Own

.026

.037

0.700

.484

Female → Intent to Own

.052

.091

0.573

.567

Susceptibility → Accept Code

.067

.025

2.652

.008*

System-efficacy → Accept Code

.049

.036

1.362

.173

Ever Owned → Accept Code

.172

.035

4.859 <.001*

Severity → Intent to Seek

.196

.143

1.366

Victim Label

.152

Addict Label
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Susceptibility → Intent to Seek

.464

.143

3.253

.001*

System-efficacy → Intent to Seek

.412

.152

2.722

.006*

Susceptibility → Intent to Own

.168

.039

4.319 <.001*

Response-efficacy → Intent to Own

.183

.053

3.458 <.001*

Ever Owned → Intent to Own

.355

.055

6.407 <.001*

Familiarity → Intent to Own

.081

.035

2.307

.021*

Female → Intent to Own

.188

.091

2.055

.040*

Hypothesis 6a
Hypothesis 6a stated that severity would be a stronger predictor of behavioral
intent for respondents receiving the threat agency message than those receiving the
human agency message. Because severity was only a significant predictor for intent to
seek information about Narcan in the overall model, this relationship was used to test the
hypothesis. Hypothesis 6a was supported. Severity was a significant predictor of intent to
seek in the threat agency group (β = 0.39, SE = 0.15, p=.008, R2=0.29). However,
severity was not a predictor in the human agency group (β = 0.18, SE = 0.14, p=.205,
R2=0.24).
Hypothesis 6b
Hypothesis 6b stated that susceptibility would be a stronger predictor of
behavioral intent for respondents receiving the threat agency message than those
receiving the human agency message. All three behavioral intent variables were
significantly predicted by perception of susceptibility in the overall model and were used
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to address this hypothesis. Regarding the Narcan coupon code acceptance, the estimates
were extremely close in both groups, with the human agency group (β = 0.07, SE = 0.03,
p=.007, R2=0.16) only slightly higher than the threat agency group (β = 0.06, SE = 0.02,
p<.008, R2=0.26). However, the statistical differences were too small to make a
meaningful interpretation. For intent to seek information about Narcan, susceptibility was
a stronger predictor in the human agency group (β = 0.52, SE = 0.14, p<.001, R2=0.24)
than the threat agency group (β = 0.34, SE = 0.16, p=.030, R2=0.29). With intent to own
Narcan, perception of susceptibility was slightly higher in the threat agency group (β =
0.14, SE = 0.05, p<.001, R2=0.35) than it was in the human agency group (β = 0.11, SE =
0.04, p=.006, R2=0.41). Differences were minimal.
The results are mixed as susceptibility was a stronger predictor of Narcan code
acceptance and intent to seek information about Narcan in the human agency group, but a
stronger predictor of intent to own in the threat agency group. However, the only intent
variable in which there was a large enough difference to make a statistically meaningful
interpretation was intention to seek information about Narcan; intention to seek
information favored the human agentic message, contradicting the predicted hypothesis.
Therefore, hypothesis 6b was not supported. The results for the linguistic agency
assignment groups are displayed in table 22.
Table 22 Linguistic Agency Assignment Group Results
Path

Estimate

S.E.

C.R.

p

.060

.023

2.645

.008*

Threat Agency
Susceptibility →Accept Code
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Table 22 Continued
System-efficacy →Accept Code

.095

.032

2.953

Ever Owned →Accept Code

.257

.050

5.113 <.001*

Severity →Intent to Seek

.394

.148

2.659

.008*

Susceptibility → Intent to Seek

.344

.159

2.165

.030*

System-efficacy → Intent to Seek

.322

.145

2.215

.027*

Susceptibility → Intent to Own

.225

.038

5.856 <.001*

Response-efficacy → Intent to Own

.141

.052

2.724

Ever Owned → Intent to Own

.381

.082

4.671 <.001*

Familiarity → Intent to Own

.047

.035

1.359

.174

Female → Intent to Own

.152

.089

1.708

.088

Susceptibility → Accept Code

.070

.026

2.706

.007*

System-efficacy → Accept Code

.023

.035

0.646

.518

Ever Owned → Accept Code

.116

.031

3.750 <.001*

Severity → Intent to Seek

.180

.142

1.267

.205

Susceptibility → Intent to Seek

.517

.142

3.647

.001*

System-efficacy → Intent to Seek

.399

.158

2.522

.012*

Susceptibility → Intent to Own

.108

.039

2.745

.006*

Response-efficacy → Intent to Own

.129

.055

2.358

.018*

Ever Owned → Intent to Own

.403

.053

7.624 <.001*

Familiarity → Intent to Own

.089

.037

2.419

.003*

.006*

Human Agency
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.016*

Table 22 Continued
Female → Intent to Own

.026

.091

0.289

.773

Hypothesis 7
Hypothesis 7 predicted the perception of system-efficacy would be a positive
predictor of behavioral intent. This hypothesis was partially supported. In the final model,
the perception of system-efficacy positively predicted both the intent to accept the Narcan
discount code (β = 0.05, SE = 0.02, p=.027, R2=0.20) and the intent to seek additional
information regarding Narcan (β = 0.35, SE = 0.11, p<.001, R2=0.26). Specifically, for
every unit increase in system-efficacy, there was a 0.05 unit increase in Narcan coupon
code acceptance and a 0.35 unit increase in intent to seek more information. The
perception of system-efficacy did not predict the intention to own Narcan in the future (β
= 0.04, SE = 0.03, p<.130, R2=0.05).
Hypothesis 8a
Hypothesis 8a predicted that system-efficacy would be a stronger predictor in the
gain-frame group when compared to the loss-frame group. This hypothesis was not
supported. There was no meaningful difference in how system-efficacy predicted
acceptance of the coupon code between the gain-frame group (β = 0.04, SE = 0.03,
p=.273, R2=0.27) and the loss-frame group (β = 0.06, SE = 0.04, p=.072, R2=0.16). There
was also no meaningful difference in how system efficacy predicted intent to seek
additional information between the gain-frame group (β = 0.44, SE = 0.14, p=.002,
R2=0.21) and the loss frame group (β = 0.32, SE = 0.16, p=.044, R2=0.34).
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Hypothesis 8b
Hypothesis 8b predicted that system-efficacy would be a stronger predictor in the
group receiving the message with the “addict” label when compared to the group
receiving the “victim” label message. This hypothesis was not supported. There was no
meaningful difference in how system-efficacy predicted acceptance of the coupon code
between the “victim” group (β = 0.06, SE = 0.03, p=.074, R2=0.15) and the “addict”
group (β = 0.05, SE = 0.04, p=.173, R2=0.24). There was also no meaningful difference
in how system efficacy predicted intent to seek additional information between the
“victim” group (β = 0.31, SE = 0.15, p=.041, R2=0.28) and the “addict” group (β = 0.41,
SE = 0.15, p=.006, R2=0.25).
Hypothesis 8c
Hypothesis 8c predicted that system-efficacy would be a stronger predictor in the
group receiving the threat agency message when compared to the group receiving the
human agency message. This hypothesis was partially supported. Perception of systemefficacy significantly predicted Narcan code acceptance in the threat agency group (β =
0.10, SE = 0.03, p=.003, R2=0.26) but not in the human agency group (β = 0.02, SE =
0.04, p=.518, R2=0.16). This was the only instance where perception of system-efficacy
was significantly impacted by a message manipulation. There was no meaningful
difference in how system-efficacy predicted intent to seek additional information between
the threat agency group (β = 0.32, SE = 0.15, p=.027, R2=0.29) and the human agency
group (β = 0.40, SE = 0.16, p=.012, R2=0.24). All system-efficacy statistics are displayed
in table 23.
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Table 23 Results for System-efficacy in Overall Model and Each Group
Path

Estimate

S.E.

C.R.

p

System-efficacy → Accept Code

.053

.024

2.211

.027*

System-efficacy → Intent to Seek

.355

.107

3.307 <.001*

System-efficacy → Accept Code

.035

.032

1.095

.273

System-efficacy → Intent to Seek

.441

.141

3.123

.002*

System-efficacy → Accept Code

.064

.036

1.796

.072

System-efficacy → Intent to Seek

.317

.158

2.011

.044*

System-efficacy → Accept Code

.056

.032

1.786

.074

System-efficacy → Intent to Seek

.305

.149

2.043

.041*

System-efficacy → Accept Code

.049

.036

1.362

.173

System-efficacy → Intent to Seek

.412

.152

2.722

.006*

System-efficacy → Accept Code

.095

.032

2.953

.003*

System-efficacy → Intent to Seek

.322

.145

2.215

.027*

.023

.035

0.646

.518

Overall Model

Gain-Frame

Loss Frame

Victim Label

Addict Label

Threat Agency

Human Agency
System-efficacy → Accept Code
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Table 23 Continued
System-efficacy → Intent to Seek

.399

.158

2.522

.012*

Research Question 1
Research question 1 asked if any other main effects or significant interactions
exist for the three message manipulations (gain-frame/loss-frame message manipulation,
victim/addict labeling manipulation, and linguistic assignment of agency). Results
revealed that the interaction between gain/loss and victim/addict for intent to own were
significant (F(1,297)= 6.510, p=.011). Specifically, participants who read a message with
the gain-frame and the “addict” labeling manipulations had significantly higher intent to
own Narcan than other combinations (Figure 8).
Results also revealed that the interaction between the “victim/addict” labels and
linguistic agency for Narcan coupon code acceptance and intent to own Narcan in the
future were significant (F(1,297)=3.858, p=.050; F(1,297)=4.166, p=.042). Specifically,
participants who received a message with the “addict” label and human agency
manipulations were significantly more likely to accept the Narcan discount code (figure
9) and indicate intent to own Narcan nasal spray (figure 10). Finally, the interaction
between all three manipulations for system efficacy was significant (F(1,297)=4.524,
p=.034) (Figure 11). Specifically, the message with the loss-frame manipulation, “addict”
label, and threat agentic message was significantly higher than the gain-frame, “victim”
label, human agentic message.
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Figure 8. Framing and Label Interaction Effect on Intent to Own

Figure 9. Label and Linguistic Agency Interaction Effect on Code Acceptance
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Figure 10. Label and Linguistic Agency Interaction Effect on Intent to Own
Several other findings unrelated to the hypotheses emerged when comparing the
gain-frame and loss-frame groups. Perception of susceptibility significantly predicted
participants’ Narcan code acceptance in the loss-frame group (β = 0.87, SE = 0.26,
p<.001, R2=0.13) but not in the gain frame group (β = 0.31, SE = 0.02, p=.181, R2=0.09).
Also, perception of severity significantly predicted intent to seek more information
concerning Narcan in the loss-frame group (β = 0.32, SE = 0.13, p=.015, R2=0.27), but
not in the gain-frame group (β = 0.18, SE = 0.14, p=.194, R2=0.14).
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Figure 11. Label and Gain-Loss Interaction Effect on Agency Plots for System-Efficacy
Extraneous Variables
Demographics
In the final model, only one demographic (gender) served as a significant
predictor. Specifically, female respondents were more likely to indicate a belief that they
would own Narcan in the future (β = 0.13, SE = 0.07, p=.043, R2=0.38). Other
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demographics including age, race, and ethnicity were not significant predictors of any
dependent variable, nor did they improve overall model fit.
Correlates
This study controlled for five separate correlates that the researcher anticipated
having high likelihood of predicting the dependent variables. Of these, two correlates did
in fact significantly predict behavioral intent. Specifically, previous ownership of Narcan
predicted intent to own Narcan in the future (β = 0.38, SE = 0.04, p<.001, R2=0.38), as
well as discount code acceptance (β = 0.15, SE = 0.03, p<.001, R2=0.20). Also,
familiarity with Narcan significantly predicted intent to own Narcan in the future (β =
0.06, SE = 0.03, p=.017, R2=0.38).
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CHAPTER V – DISCUSSION
The purpose of this project was to test messages that persuaded people to
purchase Narcan nasal spray using the EPPM as the guiding framework. The messages
were manipulated three ways, including message framing, labeling, and linguistic agency
assignment techniques. Additionally, optimistic bias and system-efficacy were measured
and tested alongside the constructs of the EPPM. The discussion of the study results is
summarized in the following sections (EPPM, optimistic bias, gain-frame/loss-frame,
labeling, linguistic agency assignment, and message manipulation interactions). An
exploration of limitations, future research, and concluding thoughts are also included.
The first measure of behavioral intent, which was acceptance or refusal of the
coupon code for Narcan nasal spray, was predicted only by susceptibility and systemefficacy. The second measure, intent to seek additional information regarding Narcan,
was predicted by severity, susceptibility, and system-efficacy. The third measure, intent
to own Narcan in the future, was predicted by susceptibility and response-efficacy.
Optimistic bias and self-efficacy did not predict any of the three behavioral intent
variables. However, when separate from the other independent variables, optimistic bias
predicted all three behavioral intent variables. Message manipulations effects are
summarized in table 24.
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Table 24 Message Manipulation Effects
Group in which variable is stronger predictor
Path

Framing

Label

Agency

Susceptibility→Accept Code

Loss-frame

-

-

Susceptibility→Seek

-

-

Human agency

Susceptibility→Future Own

-

-

-

Severity→Seek

Loss-frame

“Victim”

Threat agency

Response Efficacy→Future Own Loss-frame

“Addict”

-

System Efficacy→Accept Code

-

-

Threat agency

System Efficacy→Seek

-

-

-

EPPM
Susceptibility as the key predictor
Of the predicting variables, only susceptibility was a predictor of all three
behavioral intent indicators. System-efficacy successfully predicted two of the three
variables, and severity and response-efficacy predicted just one of three. Therefore,
susceptibility remains an integral, and perhaps the most integral, part of crafting
messages for health communication campaigns. Because an individual is unlikely to heed
a recommendation to avoid a danger that they do not think is threatening to them or to
their loved ones, messages should focus on perceived susceptibility. As the number of
opioid overdoses has risen since the nineties, it is possible that one reason for this
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increase is the lack of perceived susceptibility Americans have, especially towards others
such as loved ones.
The first proposition of the EPPM claims that a failure to increase threat
perceptions will prevent further processing of the message, rendering efficacy
perceptions irrelevant (Witte, 1992). Not surprisingly, because susceptibility was the
strongest predictor, response-efficacy and self-efficacy were the weakest predictors. This
finding also supports Ruiter and colleagues’ (2014) argument that susceptibility is more
important to overall threat perception than severity. The current study also reveals that
perceived threat to others motivates people to act in a similar way as a perceived threat to
self (Sampson et al., 2001). In this case, although the message does not focus on the death
of the individual receiving the message, it is still effective at motivating them to accept
the recommended behavior change.
Threat perception as a predictor of information seeking behavior
The intention to seek additional information about Narcan nasal spray was
predicted by high perceptions of both severity and susceptibility. Self-efficacy and
response-efficacy were not significant predictors of intention to seek more information.
One explanation for this result is that respondents’ who already perceived Narcan nasal
spray as an efficacious response did not need additional information before deciding
whether to heed the recommendation. However, those respondents reporting heightened
threat perceptions who were not convinced that Narcan nasal spray was an effective
response were left wanting more information than what was given them in the message.
This finding reiterates that in order for a message to be completely effective, respondents
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should have high perceptions of response efficacy. Simply convincing a person that he is
in danger is ineffective by itself.
Response-efficacy as a predictor of intent to own Narcan nasal spray
Response-efficacy was a significant predictor of intent to own Narcan. However,
response-efficacy was not a significant predictor of accepting the Narcan discount
coupon code. Although participants indicated an intention to own Narcan after reading
the messages, the insignificant finding for accepting the Narcan discount code reveals a
lack of urgency among respondents who intended to purchase the drug. A possible
explanation for this lack of urgency may be weaker perceptions of severity among
respondents who reported feeling susceptible. Perceived susceptibility was a significant
predictor of intent to own Narcan and intent to accept the Narcan discount code.
However, perceived severity predicted neither of the behavioral intention indicators.
Therefore, many participants perceived their loved ones susceptible to opioid overdoses
while also perceiving Narcan nasal spray as an effective response; however, respondents
did not view the threat so severe as to want to purchase the drug immediately. The lack of
urgency is problematic because fear appeal messages tend to have weaker impact on
long-term behavior (Hastings & Stead, 2004). Participants who reported both an intent to
purchase Narcan but a subsequent refusal to purchase immediately will likely never
obtain the life-saving medication unless they encounter additional pro-Narcan messages
later.
The absence of self-efficacy as a predictor of behavior
The inability of self-efficacy to predict behavioral intention was an unexpected
finding, particularly because the EPPM positions self-efficacy as a direct antecedent of
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behavioral intention. However, the current study deviates from other studies that measure
the relationship between self-efficacy and behavioral intention. In the current study, the
danger communicated (loved ones overdosing) was likely perceived as a threat to others
and not a perceived threat to self. Although the message attempts to raise the awareness
that opioids could harm ‘your loved ones’ and not 'you,’ the unique message
manipulation likely affected participants’ perceptions of self-efficacy in an unintended
way. These results seem to indicate that if a threat does not impact a person directly, selfefficacy may not play a significant role in his or her behavioral intentions.
Optimistic Bias
The overly optimistic perception of loved ones
Results of the current study confirm what much of the optimistic bias literature
posits, which is an overwhelmingly optimistic feeling that loved ones will not overdose
on opioids. The unique finding in this study is that optimism was not a perception about
oneself, but rather a perception toward others. Therefore, what is the relational
“closeness” required for people to feel optimistic bias for others? Do people feel
optimistic bias for only loved ones, or can optimistic bias also be experienced for
coworkers or simple acquaintances? Instead of viewing optimistic bias as simply ‘me
compared to everyone else,’ there may be merit in considering the role of optimistic bias
in our relationships with others. Maybe the strongest feelings of optimism are for one’s
self, followed by close family, then friends, etc. There is likely some degree of
relationship strength (perhaps a simple acquaintance) where we no longer feel optimistic
about that person’s susceptibility to a threat.
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The exclusion of optimistic bias from the EPPM
When included with the variables of the EPPM (severity, susceptibility, responseefficacy, and self-efficacy), optimistic bias was not a significant predictor of any
behavioral intention items. However, optimistic bias by itself significantly predicted all
three items rather conclusively. Based on the current study, optimistic bias does not fit in
the structure of the EPPM, likely because of its theoretical similarity to susceptibility. In
fact, Turner, Skubizs, and Rimal (2011) describe optimistic bias as a difference in
perceptions of susceptibility. Therefore, the inclusion of optimistic bias in the EPPM is
redundant and unwarranted.
Perhaps the only time that optimistic bias should be used in lieu of the perception
of susceptibility is if there is a distinct comparison being made between two individuals
or groups. For example, if the purpose of a message was to convince the female
population that they are as susceptible to opioid addiction as the male population, then
optimistic bias could be used to measure the effectiveness of the message instead of
simply the perception of susceptibility. However, when this is not the case, a
measurement of optimistic bias is unnecessary.
Optimistic bias as a predictor of behavior
Regardless of its exclusion from the EPPM, optimistic bias alone serves as a
significant predictor of behavioral intent. Just as the perception of susceptibility
significantly predicted of all three intent variables, so too did optimistic bias when alone.
When discussing the opioid crisis., those tasked with communicating the seriousness of
the epidemic must convince message recipients that negative side effects of opioids could
very well affect them and their loved ones. Additionally, message designers should go a
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step further in convincing members of the public that they are not less overdose
susceptible when compared with the average person.
Gain-Frame/Loss-Frame
Loss-frame increases response-efficacy perceptions but not self-efficacy perceptions
This study predicted a significant difference in regard to efficacy perceptions
between participants receiving a gain-frame message and those receiving a loss-frame
message. Previous scholarship indicated that perceptions of efficacy, and self-efficacy in
particular, are impacted by whether messages are gain-framed or loss-framed (Van’t Riet,
Ruiter, Werrij, & De Vries, 2008; Van’t Riet, Ruiter, Werrij, & De Vries, 2010; Werrij,
Ruiter, Van’t Riet, & De Vries, 2011). However, self-efficacy did not predict behavioral
intention in the current study; only the path from response-efficacy to intention to seek
additional information was statistically significant. Perhaps if self-efficacy had remained
a statistically significant predictor in the model, message framing may have impacted its
predictive strength. Regardless, the results of this study show that framing a message in
terms of potential losses will increase the predictive power of response-efficacy.
Using a loss-frame impacts perceptions of threat
One important finding that resulted from the framing manipulation was that threat
perceptions predicted behavioral intent better in the loss-frame group. Specifically, the
path from perceived susceptibility to Narcan coupon code acceptance and the path from
severity to intent to own Narcan were statistically significant only in the loss-frame
group. One explanation for this finding is that loss-frame messages may have made death
seem like a more likely outcome because it emphasized the likelihood of it actually
happening (i.e. “he or she will likely die”). Also, a sense of urgency was likely
92

communicated better in the loss-frame message as well (i.e. “Your loved one could be
next”). When attempting to increase the perception of danger concerning opioids, a
message designer should have more success if he or she emphasizes potential losses
rather than the possibility of avoiding the loss. It is important to note here that this may
not have been the case if a desirable kernel state had been used in the messages as
opposed to the undesirable kernel state.
The model fit is better in the loss-frame message
Overall, the model was more effective at predicting behavioral intent in the lossframe message. This finding may be explained through considering message kernel
states. The researcher decided to only employ an undesirable consequence as the kernel
state in both the gain-frame and loss-frame messages. The result of purchasing or not
purchasing Narcan nasal spray resulted in either a negative event happening (loved one
dying) or a negative event not happening (loved one not dying). A desirable consequence
was never used as the kernel of the message, as there are practically no desirable
consequences of purchasing Narcan other than the avoidance of negative consequences.
However, looking past the potential limitation of only having one kernel state, the
EPPM posits that if threat perceptions are low, then no further processing of the message
will occur. The threat perceptions were significantly worse predictors of behavioral intent
in the gain-frame message. Therefore, many respondents who received the gain-frame
message likely did not completely process the fear appeal. At first glance, this appears to
run contrary to the assumptions of prospect theory which posit that people will choose
options that present the potentials gains rather than potential losses (Tversky &
Kahneman, 1981). However, the potential gains likely need to be more compelling than
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simply avoiding negative consequences. Perhaps an absence of loss does not constitute a
gain. If this is true, then a message focused on saving a life, like the gain-frame messages
used in this study, should not be considered a gain-frame message because it does not
have tangible gains. Maybe instead, it should be considered a framing technique that
focuses on maintaining the norm.
Labeling
The ability of the ‘victim’ label to increase severity perceptions
Severity was a significant predictor of behavioral intent only in messages
employing the term “victim” rather than “addict.” Of the two labels, “victim” appears to
be less stigmatizing; being deemed a “victim” implies a lack of control over the situation.
Pragmatically, “victim” is a word usually employed only in serious situations of harm or
injury. For example, persons suffering from domestic abuse are often called victims, but a
child kicked by another child at recess would likely not be described as a “victim.”
Therefore, messages employing the “victim” label will likely lead to higher perceptions
of severity.
The Ability of the ‘Addict’ Label to Increase Response-Efficacy Perceptions
Although messages employing the term “victim” were helpful in increasing
perceived severity, response-efficacy was only a predictor of behavioral intention in
messages employing the term “addict.” The label “addict” was intended to be a more
stigmatizing label. Being labeled an “addict” implies both personal responsibility and a
lack of individual control. Interestingly, the “addict” label appeared to cause the audience
to perceive that Narcan nasal spray was an effective response to an overdose, more so
than the “victim” label. This may be because of the sense of finality that the word victim
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connotes. As discussed above, the term victim is usually reserved for serious incidents
that likely have already taken place. A victim may be perceived as already being dead for
instance. Narcan, in this case, would not be an effective remedy. However, labeling
someone an addict does not similarly indicate that it is too late, or that he has already
passed away. If the addict is still alive, then being prepared with Narcan in case he does
overdose would appear to be an efficacious response.
Labels should be carefully considered based upon intended perception
With severity and response-efficacy having mixed results in terms of labeling, the
question remains as to which label should be used when designing messages. The answer,
according to the data from this study, is that they should be interchanged depending on
the purpose of each statement within the message. Statements trying to invoke a sense of
danger should use the “victim” label (i.e. everyone around you is a potential victim to the
opioid crisis). Statements trying to invoke a sense of efficacy should use the “addict”
label (i.e. Narcan nasal spray can revive addicts who have overdosed). For instance, a
situation where the intended audience likely knows little about the dangers of opioids,
such as adolescents, would need to be convinced of the severity of the threat. Conversely,
first responders may need only to be convinced of the effectiveness of Narcan. The label
used should be dependent on the purpose of the message and which audience perceptions
are desired. Further research should confirm that this strategy is effective.
Linguistic Agency Assignment
The perception of severity is higher in threat agentic messages
As anticipated, severity was only predictive of behavioral intent when agency was
assigned linguistically to the threat (i.e. “opioids killed” instead of “Americans died”).
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This adds to the body of literature that argues linguistically assigning a threat with
agency, rather than a human, prompts readers to perceive the threat as more serious and
will likely cause them to be more supportive of actions protecting the public from the
threat (McGlone, Bell, Zaitchik, & McGlynn III, 2013; Bell, McGlone, & Dragojevic,
2014a; Bell, McGlone, & Dragojevic, 2014b; Dragojevic, Bell, & McGlone, 2014;
Glowacki, McGlone, & Bell, 2016). This reinforces the argument that linguistic agency
assignment is a significantly effective tactic at persuading people that a threat is harmful.
This is very useful for agencies or communication practitioners who have the task of
convincing others to act in potentially harmful situations. For example, communities that
have experienced a high number of hurricane warnings may be harder to motivate to
evacuate because of low threat severity perceptions (Anthony & Sellnow, 2011).
The perception of susceptibility in human agentic messages predicts information seeking
behavior
While the current findings regarding severity align with past research, the current
findings for susceptibility are at odds with many previous studies. In the current study.
susceptibility was revealed a stronger predictor of behavioral intent in messages where
agency was linguistically assigned to humans. Chen, McGlone, and Bell (2015) also
found agency assignment to humans, rather than to colon cancer, elevated perceptions of
susceptibility. Chen et al. (2015) argued, “This unexpected finding might be explained by
the locus of the threats studied to date” (p. 984). They continue, “Bacteria, viruses, and
radon gas emanate from outside people and come to them to produce harm. In contrast,
colon cancer originates from within the person; indeed, the threat is the person’s own
mutating cells” (p. 984).
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The findings of the current study lend support to Chen et al.’s (2015) use of locus
as the predictor of perceptions of susceptibility. While opioids do not originate in the
human body like cancer cells, individuals make the decision to consume opioids, whether
prescription or illicit. Addiction can also be considered an internal threat. Additionally,
those who are addicted to opioids may take doses that they know are dangerous. The
decision to use the drug recreationally or take a dosage higher than recommended is made
internally. On the other hand, a bacterium, virus, or radon gas can endanger unsuspecting
individuals without any action taken or consent provided by the person. Instead, the
current study focuses on addiction and the conscious decision made by individuals who
knowingly risk ingesting opioids.
System-Efficacy
The perception of system-efficacy is a strong predictor of behavior
Although not an original construct in Witte’s (1992) EPPM, the perception of
system-efficacy served as a strong predictor of behavioral intent in the current study. As
discussed above, system-efficacy was significant in the final model while self-efficacy
was not a significant predictor of behavioral intent. This finding is noteworthy for future
EPPM studies. While the current study is not arguing for system-efficacy to replace selfefficacy as a staple construct in the EPPM, our findings suggest when a perceived threat
is more likely to affect individuals external to the individual, such as loved ones, systemefficacy is a better predictor of behavioral intent than self-efficacy. For example, if the
messages in this study had attempted to persuade readers to dispose of old opioid to avoid
potential self-harm, perhaps self-efficacy would have been a stronger predictor of
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behavioral intention than system-efficacy. However, because the potential threat was the
death of a loved one, self-efficacy was no longer salient to the participants.
To better understand how system-efficacy affected the outcome variables in this
study, it is imperative to understand what respondents perceived as “the system”. The
system in this case, based upon the items from the survey, represented several different
entities that can serve to protect loved ones, including organizations or agencies that want
to protect the public from the opioid crisis, the government, friends and family,
pharmaceutical researchers, and scientists. It was respondents’ perceptions of these
entities, and their ability to protect the respondents’ loved ones, that made up the
perception of system-efficacy.
The lack of salience of self-efficacy among participants may have resulted from
the little control individuals perceive they have in protecting loved ones. For instance, if a
mother sends her child to school on the bus, she has lost the ability to protect the child
from harm during the commute to school; she now must rely on a variety of others to
protect the child, including the bus driver, school teachers, and even other children. The
likelihood of the child’s safe return home is completely out of the control of the mother,
and her perception and confidence that her child will return safely can be operationally
defined as system-efficacy. In the context of health communication campaigns, if the
recommended behavior or attitude change is intended to protect others from a threat
rather than oneself, an emphasis on system-efficacy in campaign messages may serve as a
stronger predictor of intention to accept the recommendation than self-efficacy.
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Threat agentic messages increase the power of system-efficacy perceptions
The threat agentic message rather than the human agentic message was the only
message manipulation that significantly increased perceptions of system-efficacy. Giving
opioids agency resulted in system-efficacy being a predictor of behavioral intent. Threat
agency language removes the power of action from the individual, and as explained in the
example of the mother sending her child to school, when a person perceives that she has
lost personal control, she will tend to rely more heavily on the greater system. Therefore,
the finding of threat agentic messages increasing system-efficacy perceptions further
advances the importance of using system-efficacy over self-efficacy when the message
communicates a threat to others.
Message Manipulation Interactions
System-efficacy thrives in the loss-frame/addict/threat agency message
Three significant interactions were found between message manipulations. The
first interaction, and the only one that included a combination of all three manipulations,
revealed that the loss-frame/“addict” label/threat agentic (LAT) message resulted in the
highest perceptions of system-efficacy. This finding supports the argument for the
inclusion of system-efficacy when the threat affects the individual indirectly. When the
danger is a perceived threat to others and not to the self, system-efficacy is more
important than self-efficacy in predicting behavioral intent. In the LAT message, all three
manipulations take control away from the individual. While the loss-frame message
likely produces images of overdosed, and even dead loved ones, the addict label likely
conjures images of helpless loved ones. Additionally, using threat agency takes ability
away from the human. All three message characteristics take power away from the
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message recipient. Therefore, they must put their trust in the hands of the system, rather
than themselves. This could explain why the LAT message led to the highest levels of
perceived system-efficacy.
The ‘addict’ label in a gain-frame message significantly increases intent to own Narcan
The second interaction was between “addict” and “victim” labeling and gainframe/loss-frame messages. Behavioral intent was significantly increased when the
“addict” label was employed in a gain-frame message. An example phrase employing
both tactics is, “you can save the life of an addict by using Narcan nasal spray.” As
mentioned above, response-efficacy was significantly increased in the “addict” labeled
messages. The combination of the heightened response-efficacy perception (through the
“addict” label) with the perception of a positive outcome (resulting from gain-framing)
resulted in a significantly higher likelihood of intending to own Narcan nasal spray.
The interaction effects between the “addict” label and gain-frame messages
deviates from the main effects of the study because on the whole, the loss-frame message
was more likely to increase behavioral intent than the gain-frame message. When
combined with the “addict” label however, the gain-frame message was more salient.
There may be an incongruency between the “victim” and the gain-frame message. The
“victim” label implies the negative event has already happened and saving him is less
likely to happen. Alternatively, the “addict” can still be saved, and has not yet become a
victim through overdosing on opioids, and possibly even death.
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The ‘addict’ label in a human agency message significantly increases intent to own and
accept the discount code for Narcan
The final significant interaction occurred in the messages employing the “addict”
label in human agentic phrasing (i.e. when addicts ingest too many opioids, their
breathing is suppressed, and they suffocate). The notion that opioids independently
caused the overdose (threat agency) and the idea of the individual’s addiction causing the
overdose (“addict” label) are mutually exclusive. Giving opioids agency in suffocating a
person positions the drugs as an active assailant and the individual as a victim rather than
an addict. This contradiction of responsibility may negatively impact the processing of
the message, and ultimately, the perceptions of threat and efficacy. To avoid this, a
message that employs the victim label should be ascribing agency to the threat. Further
research should seek to better understand this finding.
Demographics
Gender predicts intent to own Narcan
As the only demographic variable that predicted behavioral intent, female
participants were significantly more likely to indicate an intent to own Narcan in the
future. One potential explanation for this finding is gender and risk aversion. Rosen, Tsai,
and Downs (2003), for example, found female participants to have significantly higher
rates of risk aversion than male participants when imagining different health states.
Therefore, a stronger desire to avoid health risks among female participants could
certainly explain the higher intent to own Narcan.
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Limitations
One limitation of the current study was that all messages had an undesirable
consequence kernel state, regardless of whether a gain-frame or loss-frame was
employed. This decision was made because loss of life (or preventing loss of life) is the
primary reason that Narcan is ever used in overdose situations. Therefore, only the
undesirable kernel state was used.
Second, although reading checks, attention checks, and time requirements were
implemented to protect the dataset from “careless” participants, there still may have been
a small number of respondents who took the survey with some degree of carelessness.
There is a possibility that some participants read only the parts of the message that they
needed to answer the reading check questions correctly. However, even if the minimal
amount of reading was done, the checks ensured that all manipulations were read and
processed.
Third, because participants across the United States were sampled, there was
likely a difference in perception of the opioid crisis between participants prior to taking
the survey. For example, participants from the Midwest or Southeast, areas of the country
where the epidemic has hit the hardest, and participants from the West Coast may have
had different initial perceptions of severity and susceptibility before reading the study
message. Location was not controlled for in the analysis, and therefore could have
impacted the results to some degree.
Fourth, only two labels were used to test stigmatization through language. While
“victim” and “addict” certainly shed light on this discussion, several other labels could
have been used such as “user”, and “abuser”, or even more extreme labels such as
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“crackhead”. There are many ways that individuals who abuse opioids can be negatively
stigmatized through language, and each may affect message processing in a different
way. In order to get a firm grasp on how stigmatizing labels impact perceptions of
individuals who have overdosed, a broader pool of labels need to be tested.
Future Research
Based on the results of the current study, five areas for potential future research
are offered. First, one of the primary findings of the current study is that system-efficacy
is a better predictor of behavioral intention than self-efficacy when the danger is
perceived more as a threat to others than a threat to oneself. Additional studies should
further investigate the difference between perceptions of system-efficacy and selfefficacy, and in what circumstances system-efficacy may be a better predictor of
behavior. For instance, two fear appeal messages focused on the same threat could be
helpful in this endeavor. If one message positioned the threat as affecting others (external
to the individual) while the other positioned the threat as directly affecting the individual,
the researcher could then compare the two groups.
A second argument requiring further research focuses on the interplay of levels of
optimistic bias and the degree of relationship. Based on the findings of the current study,
if a less intimate relationship exists between the respondent and the person in danger, the
optimistic bias should be lower. Alternatively, if the relationship is more intimate,
individuals will experience higher levels of optimistic bias when confronted with
potential threats to persons close to them. Future research should measure optimism for
one’s self, optimism for family members, optimism for friends, optimism for co-workers,
and so on. Results could determine if optimistic bias increases with intimacy.
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Third, the current study revealed the “addict” label increased perceptions of
response-efficacy among respondents while the “victim” label increased perceptions of
severity. It was argued in this study that both labels should be employed in the
appropriate places throughout the message to increase both perceptions. However, it is
unknown if there would be unintended consequences of doing so. For instance, if a
message labeled people as victims in one sentence and addicts in another, the processing
of both labels may interact negatively, decreasing behavioral intent likelihood. Therefore,
a message should be created using this strategy to see if the results play out as
anticipated, or if the negative interaction occurs.
Finally, the interaction between the “addict” label and the human agentic message
resulted in a higher intent to change behavior. The two possible explanations
hypothesized here include 1) the idea that addiction as the cause and opioid agency as the
cause are mutually exclusive, and 2) that the “addict” label and the human agency
message independently raised susceptibility. Further research should attempt to clarify
which hypothesis is a better explanation. How these language variables interact needs to
be parsed out further.
Conclusion
The purpose of the current study was to identify message strategies for persuading
people to purchase Narcan. Based on the findings from this study, a final version of the
message was created with the recommended characteristics (Figure 12). In instances
where the message should increase threat perceptions, a loss-frame is employed (i.e.
“opioid victims are dying”). The “victim” label is used in instances where perceptions of
severity should be increased (i.e. “Opioid pills and heroin killed over 63,000 victims”).
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The “addict” label is used in instances where response-efficacy should be increased (i.e.
“When an addict has overdosed, spray Narcan into their nostrils or they could die”).
Threat agency assignments are made in instances where severity is to be increased (i.e.
“An opioid overdose occurs when opioids take over the brain and suffocate the victim”).
And human agency assignments are made in instances where susceptibility is to be
increased (i.e. “People from all genders, races, and classes are overdosing on opioids”).
This message represents the practical implications of this study.
Theoretical implications affect several areas of research. System-efficacy and its
possible inclusion in the EPPM under certain circumstances is an impactful finding. This
increases scholarly understanding of how risk messages are processed, and what
communication variables impact behavior. The way people are labeled and stigmatized in
messages does carry consequences for message processing as well. Finally, the study
sheds additional light on the way linguistic agency assignments impact perceptions of
susceptibility. Specifically, a threat’s perceived locus may prevent threat agentic
assignments from increasing susceptibility.
In conclusion, the opioid crisis that has plagued America for over three decades
has only become a larger problem with an increasing number of casualties. It will take a
concentrated effort from every corner, including prescription and pharma regulation,
addiction recovery, first response efforts, and more. What cannot be overlooked or
understated is the importance that communication campaigns can have in reversing the
epidemic. Education and awareness are at the heart of any public health initiative. The
crisis will likely never be resolved without a better public understanding of the tools
(such as Narcan) that are available to reconcile the issue. The results of this study can
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inform message design for such campaigns. A knowledge of how small but important
message characteristics, such as labels, agency, and framing, can impact threat and
efficacy perceptions can significantly improve campaign outcomes. It will be attention to
details, such as campaign messages and how they’re presented, that can save lives and
end the opioid epidemic.

Figure 12. Final Message with Study Recommendations
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APPENDIX A – SURVEY INSTRUMENT
Reading Validity Check Questions
1. In the message above, what does the second line that is written in black say?
Answer options dependent on message assigned
2. How many victims does the message say were killed by opioid pills and heroin in
2016?
a. Over 12,000

b. Over 5,000

c. Over 63,000

3. In the message above, what does the first line that is written in pink say?
Answer options dependent on message assigned
Attention Validity Check Question
1. I am taking a survey.
1 (Strongly Disagree) – 6 (Strongly Agree)
Optimistic Bias Items
1. What are the odds that one of your loved ones will overdose on opioids or heroin?
0 (Not likely at all) - 10 (Extremely likely)
2. What are the odds of that the average person will overdose on opioids or heroin?
0 (Not likely at all) - 10 (Extremely likely)
Self-Efficacy Scale
1. Narcan nasal spray is easily available to me.
1 (Strongly Disagree) - 6 (Strongly Agree)
2. I have the ability to use Narcan nasal spray if required.
1 (Strongly Disagree) - 6 (Strongly Agree)
3. There is nothing preventing me from using Narcan nasal spray.
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1 (Strongly Disagree) - 6 (Strongly Agree)
4. Narcan nasal spray is easy to use.
Response-efficacy Scale
1. Narcan nasal spray will prevent the death of a loved one who has overdosed.
1 (Strongly Disagree) - 6 (Strongly Agree)
2. My loved ones are less likely to die from an overdose if I have Narcan nasal spray.
1 (Strongly Disagree) - 6 (Strongly Agree)
3. Narcan nasal spray is effective in ending the threat of a loved one dying from an
overdose.
1 (Strongly Disagree) - 6 (Strongly Agree)
4. If someone has overdosed on opioids, I believe Narcan nasal spray can save them.
1 (Strongly Disagree) - 6 (Strongly Agree)
System-efficacy Scale
1. I believe there are organizations or agencies that want to protect me from the opioid
crisis.
1 (Strongly Disagree) - 6 (Strongly Agree)
2. The government will help me respond to the opioid crisis.
1 (Strongly Disagree) - 6 (Strongly Agree)
3. My friends and family will protect me from the opioid crisis.
1 (Strongly Disagree) - 6 (Strongly Agree)
4. Pharmaceutical researchers and scientists want to protect me from the opioid crisis.
1 (Strongly Disagree) - 6 (Strongly Agree)
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Threat Severity Scale
1. Opioids pose a serious risk to my loved ones.
1 (Strongly Disagree) - 6 (Strongly Agree)
2. Opioids are potentially harmful to my loved ones.
1 (Strongly Disagree) - 6 (Strongly Agree)
3. Opioids are a severe threat to my loved ones.
1 (Strongly Disagree) - 6 (Strongly Agree)
4. My friends could die from using opioids.
1 (Strongly Disagree) - 6 (Strongly Agree)
Threat Susceptibility Scale
1. My loved ones are at risk for being an opioid overdose victim.
1 (Strongly Disagree) - 6 (Strongly Agree)
2. It is possible that one of my loved ones will overdose on opioids.
1 (Strongly Disagree) - 6 (Strongly Agree)
3. I believe that one of my loved ones could be a victim of the opioid crisis.
1 (Strongly Disagree) - 6 (Strongly Agree)
4. An opioid overdose could happen to one of my loved ones.
1 (Strongly Disagree) - 6 (Strongly Agree)
Behavioral Intent
1. Helprx.info is currently offering a 75% off coupon for Narcan. Would you like a link
to this offer?
Yes

No

2. Do you think you will ever own Narcan nasal spray?
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Definitely Not

Probably Not

Probably Yes

Definitely Yes

3. Do you plan on seeking more information about opioids or Narcan nasal spray?
Definitely Not

Probably Not

Probably Yes

Definitely Yes

4. How likely are you to seek information about Narcan nasal spray?
1 (Extremely unlikely) - 7 (Extremely likely)
Correlates
1. Have you ever owned Narcan nasal spray?
Definitely Not

Probably Not

Probably Yes

Definitely Yes

Probably Yes

Definitely Yes

2. Have you ever used Narcan nasal spray?
Definitely Not

Probably Not

3. Has someone close to you ever overdosed on opioids or heroin?
Definitely Not

Probably Not

Probably Yes

Definitely Yes

4. Before taking this survey, did you know what Narcan nasal spray was?
Definitely Not

Probably Not

Probably Yes

Definitely Yes

5. How familiar were you with Narcan nasal spray prior to taking this survey?
1 (Not familiar at all) - 5 (Extremely familiar)
Demographics
1. What best describes your sex?
Male

Female

Other or prefer not to disclose

2. What best describes your race?
White
Black or African American
Asian
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American Indian or Alaska Native
Native Hawaiian or Pacific Islander
Other
3. What best describes your age?
18-24 25-34 35-44 45-54 55-64 65-74 75+
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APPENDIX B – STUDY MESSAGES

Gain-Frame/Addict/Human Agency Message

Gain-Frame/Addict/Threat Agency Message
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Gain-Frame/Victim/Human Agency Message

Gain-Frame/Victim/Threat Agency Message
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Loss-Frame/Addict/Human Agency Message

Loss-Frame/Addict/Threat Agency Message
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Loss-Frame/Victim/Human Agency Message

Loss-Frame/Victim/Threat Agency Message
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